<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006053.pub6" GROUP_ID="UPPERGI" ID="726705043011510768" MERGED_FROM="" MODIFIED="2016-02-07 21:23:58 +0000" MODIFIED_BY="Karin Dearness" REVIEW_NO="96" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2016-02-07 21:23:58 +0000" MODIFIED_BY="Karin Dearness">
<TITLE MODIFIED="2011-03-16 12:22:17 -0400" MODIFIED_BY="Karin Dearness">Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma</TITLE>
<CONTACT MODIFIED="2016-02-07 21:23:58 +0000" MODIFIED_BY="Karin Dearness"><PERSON ID="E3E12B6482E26AA201D6C275388F54B2" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Markus</FIRST_NAME><MIDDLE_INITIALS>W</MIDDLE_INITIALS><LAST_NAME>Büchler</LAST_NAME><POSITION>Professor of Surgery</POSITION><EMAIL_1>markus_buechler@med.uni-heidelberg.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of General, Visceral and Transplant Surgery</DEPARTMENT><ORGANISATION>University of Heidelberg</ORGANISATION><ADDRESS_1>Im Neuenheimer Feld 10</ADDRESS_1><CITY>Heidelberg</CITY><ZIP>69120</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 6221 56 ext: 6200</PHONE_1><FAX_1>+49 6221 56  5450</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-02-07 21:23:58 +0000" MODIFIED_BY="Karin Dearness"><PERSON ID="z1312041446561539647914960350157" ROLE="AUTHOR"><FIRST_NAME>Felix</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Hüttner</LAST_NAME><EMAIL_1>Felix.Huettner@med.uni-heidelberg.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of General, Visceral and Transplant Surgery</DEPARTMENT><ORGANISATION>University of Heidelberg</ORGANISATION><ADDRESS_1>Im Neuenheimer Feld 110</ADDRESS_1><CITY>Heidelberg</CITY><ZIP>69120</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 6221 56 35114</PHONE_1></ADDRESS></PERSON><PERSON ID="64117078022340607292100518223049" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Christina</FIRST_NAME><LAST_NAME>Fitzmaurice</LAST_NAME><EMAIL_1>cf11@uw.edu</EMAIL_1><ADDRESS><DEPARTMENT>Hematology-Oncology</DEPARTMENT><ORGANISATION>University of Washington/Fred Hutchinson Cancer Research Center</ORGANISATION><ADDRESS_1>1100 Fairview Ave N &#8211; D5-100</ADDRESS_1><ADDRESS_2>PO Box 19024</ADDRESS_2><CITY>Seattle</CITY><ZIP>98109-1024</ZIP><REGION>Washington State</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON><PERSON ID="5936" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Guido</FIRST_NAME><LAST_NAME>Schwarzer</LAST_NAME><POSITION>Senior Statistician</POSITION><EMAIL_1>sc@imbi.uni-freiburg.de</EMAIL_1><ADDRESS><DEPARTMENT>Center for Medical Biometry and Medical Informatics</DEPARTMENT><ORGANISATION>Medical Center - University of Freiburg</ORGANISATION><ADDRESS_1>Stefan-Meier-Str. 26</ADDRESS_1><CITY>Freiburg</CITY><ZIP>D-79104</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 761 203 6668</PHONE_1><FAX_1>+49 761 203 6680</FAX_1></ADDRESS></PERSON><PERSON ID="16704" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Christoph</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Seiler</LAST_NAME><SUFFIX>MSc</SUFFIX><EMAIL_1>c.seiler@jhwaf.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of General, Visceral and Transplant Surgery</DEPARTMENT><ORGANISATION>University of Heidelberg</ORGANISATION><ADDRESS_1>Im Neuenheimer Feld 110</ADDRESS_1><CITY>Heidelberg</CITY><ZIP>69120</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 6221 56 ext: 6980</PHONE_1><FAX_1>+49 6221 56 6988</FAX_1></ADDRESS></PERSON><PERSON ID="5929" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Gerd</FIRST_NAME><LAST_NAME>Antes</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>antes@cochrane.de</EMAIL_1><URL>http://www.cochrane.de</URL><ADDRESS><DEPARTMENT>Cochrane Germany</DEPARTMENT><ORGANISATION>Medical Center - University of Freiburg</ORGANISATION><ADDRESS_1>Berliner Allee 29</ADDRESS_1><CITY>Freiburg</CITY><ZIP>79110</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 761 203 6715</PHONE_1><FAX_1>+49 761 203 6712</FAX_1></ADDRESS></PERSON><PERSON ID="E3E12B6482E26AA201D6C275388F54B2" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Markus</FIRST_NAME><MIDDLE_INITIALS>W</MIDDLE_INITIALS><LAST_NAME>Büchler</LAST_NAME><POSITION>Professor of Surgery</POSITION><EMAIL_1>markus_buechler@med.uni-heidelberg.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of General, Visceral and Transplant Surgery</DEPARTMENT><ORGANISATION>University of Heidelberg</ORGANISATION><ADDRESS_1>Im Neuenheimer Feld 10</ADDRESS_1><CITY>Heidelberg</CITY><ZIP>69120</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 6221 56 ext: 6200</PHONE_1><FAX_1>+49 6221 56  5450</FAX_1></ADDRESS></PERSON><PERSON ID="C10C577682E26AA201650CEA8740823D" ROLE="AUTHOR"><FIRST_NAME>Markus</FIRST_NAME><MIDDLE_INITIALS>K</MIDDLE_INITIALS><LAST_NAME>Diener</LAST_NAME><EMAIL_1>Markus.Diener@med.uni-heidelberg.de</EMAIL_1><EMAIL_2>diener@cochrane.de</EMAIL_2><ADDRESS><DEPARTMENT>Department of General, Visceral and Transplant Surgery</DEPARTMENT><ORGANISATION>University of Heidelberg</ORGANISATION><ADDRESS_2>Im Neuenheimer Feld 110</ADDRESS_2><CITY>Heidelberg</CITY><ZIP>69120</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 6221 56 6986</PHONE_1><FAX_1>+49 6221 56 6988</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-12-01 13:09:15 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 02/02/08&lt;/p&gt;" NOTES_MODIFIED="2015-12-01 13:09:15 -0500" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="12" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="18" MONTH="8" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="12" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="8" YEAR="2015"/>
<DESCRIPTION>
<P>2 new trials incorporated, conclusions were not changed. However, pooled result for red blood cell transfusion turned significant in favour of PPW. Furthermore, DGE turned significant in favour of CW due to the inclusion of the new trials.</P>
<P>Hanns-Peter Knaebel is no longer an author of this Cochrane review due to his commercial relationships.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="8" YEAR="2015"/>
<DESCRIPTION>
<P>Searches rerun and results incorporated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-08-18 13:30:50 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="6" YEAR="2015"/>
<DESCRIPTION>
<P>Hanns-Peter Knaebel's declaration of interest statement updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-02-05 04:38:41 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="11" YEAR="2014"/>
<DESCRIPTION>
<P>Details of NIH funding held by review author included in acknowledgements.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-11-18 12:20:59 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="5" YEAR="2014"/>
<DESCRIPTION>
<P>Study flow diagram added as a figure. Some minor errors revised.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-07-10 15:28:27 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="4" YEAR="2011"/>
<DESCRIPTION>
<P>No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-07-10 15:28:22 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="2" YEAR="2011"/>
<DESCRIPTION>
<P>No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-02-23 14:22:33 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>Withdrawn while results of updated literature search were incorporated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-01-04 14:01:24 -0500" MODIFIED_BY="Karin L Dearness">
<DATE DAY="5" MONTH="10" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<DATE DAY="12" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to RevMan 5 format. 'Risk of bias' table added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-10-05 09:45:56 -0400" MODIFIED_BY="Karin Dearness">
<DATE DAY="29" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">Comparison of the stomach-preserving versus classic 'Whipple' operation for people with cancer of the pancreas or the periampullary region</TITLE>
<SUMMARY_BODY MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>
<B>Review question</B>
</P>
<P>It is unclear whether the pylorus-preserving Whipple procedure results in a higher rate of recurrence of the tumour because it is less extensive and therefore may be less radical, but it is also unknown whether quality of life is decreased after removal of the lower portion of the stomach. Another uncertainty is whether the two methods are associated with different rates or types of complications.</P>
<P>
<B>Background</B>
</P>
<P>Pancreatic cancer is a leading cause of cancer death. Two surgical procedures can lead to a cure: the classic Whipple operation, in which part of the pancreas, the gallbladder, the duodenum, the pylorus (outlet of the stomach), and the distal (lower) part of the stomach are removed, and the so-called pylorus-preserving pancreaticoduodenectomy, or pylorus-preserving Whipple operation, in which the stomach and the pylorus are not removed.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We included eight randomised controlled trials with a total of 512 participants in this review. The included trials revealed vast differences in sample size as well as clinical and methodological quality.</P>
<P>
<B>Key results</B>
</P>
<P>We could identify no relevant differences in terms of main complications, long-term survival, or death due to complications after the operation, but operating time, intraoperative blood loss, and need for blood transfusion seem to be less frequent in the group treated with the pylorus-preserving Whipple operation. Our conclusion is that, at present, no relevant difference is evident between the two surgical procedures for the treatment of pancreatic or periampullary cancer.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The quality of the body of evidence is still low since all trials revealed some shortcomings in terms of methodological quality or reporting.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Pancreatic cancer is the fourth-leading cause of cancer death for both, men and women. The standard treatment for resectable tumours consists of a classic Whipple (CW) operation or a pylorus-preserving pancreaticoduodenectomy (PPW). It is unclear which of these procedures is more favourable in terms of survival, postoperative mortality, complications, and quality of life.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>The objective of this systematic review was to compare the effectiveness of CW and PPW techniques for surgical treatment of cancer of the pancreatic head and the periampullary region.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-02-05 10:20:57 -0500" MODIFIED_BY="[Empty name]">
<P>We conducted searches on 28 March 2006, 11 January 2011, 9 January 2014, and 18 August 2015 to identify all randomised controlled trials (RCTs), while applying no language restrictions. We searched the following electronic databases on 18 August 2015: the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effects (DARE) from the Cochrane Library (2015, Issue 8); MEDLINE (1946 to August 2015); and EMBASE (1980 to August 2015). We also searched abstracts from Digestive Disease Week and United European Gastroenterology Week (1995 to 2010); we did not update this part of the search for the 2014 and 2015 updates because the prior searches did not contribute any additional information. We identified two additional trials through the updated search in 2015.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>RCTs comparing CW versus PPW including participants with periampullary or pancreatic carcinoma.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Two review authors independently extracted data from the included trials. We used a random-effects model for pooling data. We compared binary outcomes using odds ratios (ORs), pooled continuous outcomes using mean differences (MDs), and used hazard ratios (HRs) for meta-analysis of survival. Two review authors independently evaluated the methodological quality and risk of bias of included trials according to the standards of The Cochrane Collaboration.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>We included eight RCTs with a total of 512 participants. Our critical appraisal revealed vast heterogeneity with respect to methodological quality and outcome parameters. Postoperative mortality (OR 0.64, 95% confidence interval (CI) 0.26 to 1.54; P = 0.32), overall survival (HR 0.84, 95% CI 0.61 to 1.16; P = 0.29), and morbidity showed no significant differences, except of delayed gastric emptying, which significantly favoured CW (OR 3.03, 95% CI 1.05 to 8.70; P = 0.04). Furthermore, we noted that operating time (MD -45.22 minutes, 95% CI -74.67 to -15.78; P = 0.003), intraoperative blood loss (MD -0.32 L, 95% CI -0.62 to -0.03; P = 0.03), and red blood cell transfusion (MD -0.47 units, 95% CI -0.86 to -0.07; P = 0.02) were significantly reduced in the PPW group. All significant results were associated with low-quality evidence based on GRADE (Grades of Recommendation, Assessment, Development and Evaluation) criteria.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Current evidence suggests no relevant differences in mortality, morbidity, and survival between the two operations. However, some perioperative outcome measures significantly favour the PPW procedure. Given obvious clinical and methodological heterogeneity, future high-quality RCTs of complex surgical interventions based on well-defined outcome parameters are required.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Pancreatic cancer is the fourth-leading cause of cancer death for men and women. Whereas overall cancer death rates have been decreasing since the early 1990s, the incidence and death rate of pancreatic cancer continues to increase in recent years (<LINK REF="REF-Kohler-2015" TYPE="REFERENCE">Kohler 2015</LINK>). Pancreatic cancer accounts for 6.6% of cancer deaths in men and 7.2% in women (<LINK REF="REF-Siegel-2015" TYPE="REFERENCE">Siegel 2015</LINK>). In large retrospective studies and randomized controlled trials, the aggressive nature of these tumours and the high local recurrence rate, together with early metastatic spread, have resulted in disappointing five-year survival rates of between 20% and 24% after resection together with adjuvant treatment strategies (<LINK REF="REF-Cameron-2015" TYPE="REFERENCE">Cameron 2015</LINK>; <LINK REF="REF-Oettle-2013" TYPE="REFERENCE">Oettle 2013</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>The current standard therapy for pancreatic tumours situated in the head of the pancreas is resection (<LINK REF="REF-Buchler-2003" TYPE="REFERENCE">Buchler 2003</LINK>; <LINK REF="REF-Lillemoe-2000" TYPE="REFERENCE">Lillemoe 2000</LINK>). Great improvements in pancreatic surgery have led to mortality rates of less than 5% at high-volume centres (<LINK REF="REF-Buchler-2003" TYPE="REFERENCE">Buchler 2003</LINK>; <LINK REF="REF-Cameron-2015" TYPE="REFERENCE">Cameron 2015</LINK>; <LINK REF="REF-Trede-1990" TYPE="REFERENCE">Trede 1990</LINK>; <LINK REF="REF-Yeo-1997" TYPE="REFERENCE">Yeo 1997</LINK>). Moreover, mortality and morbidity rates after resection have reached similar levels to those following the palliative bypass operation (<LINK REF="REF-Gouma-1999" TYPE="REFERENCE">Gouma 1999</LINK>; <LINK REF="REF-Koslowsky-2001" TYPE="REFERENCE">Koslowsky 2001</LINK>; <LINK REF="REF-Lillemoe-1996" TYPE="REFERENCE">Lillemoe 1996</LINK>). Nevertheless, operative morbidity remains high, occasionally approaching 30% to 45% (<LINK REF="REF-Bassi-2001" TYPE="REFERENCE">Bassi 2001</LINK>; <LINK REF="REF-Cameron-2015" TYPE="REFERENCE">Cameron 2015</LINK>; <LINK REF="REF-Gouma-2000" TYPE="REFERENCE">Gouma 2000</LINK>; <LINK REF="REF-Richter-2003" TYPE="REFERENCE">Richter 2003</LINK>), from causes including intra-abdominal abscess, sepsis, pancreatic fistula, and delayed gastric emptying (DGE).</P>
<P>One of two surgical techniques is typically performed in the treatment of cancer of the pancreatic head: the classic Whipple (CW) operation developed by Kausch, in <LINK REF="REF-Kausch-1912" TYPE="REFERENCE">Kausch 1912</LINK>, and later perfected by Whipple, in <LINK REF="REF-Whipple-1935" TYPE="REFERENCE">Whipple 1935</LINK>, and the pylorus-preserving Whipple (PPW) operation inaugurated by Watson, in <LINK REF="REF-Watson-1944" TYPE="REFERENCE">Watson 1944</LINK>, and popularised by Traverso and Longmire, in <LINK REF="REF-Traverso-1980" TYPE="REFERENCE">Traverso 1980</LINK>.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>The CW operation consists of an en bloc (as one unit) removal of the pancreatic head, the duodenum, the common bile duct, the gallbladder, and the distal portion of the stomach, together with adjacent lymph nodes (<LINK REF="REF-Trede-1993" TYPE="REFERENCE">Trede 1993</LINK>). This operation can lead to special complications such as early and late dumping (rapid emptying of the stomach), postoperative weight loss (<LINK REF="STD-Seiler-2000" TYPE="STUDY">Seiler 2000</LINK>), and postoperative reflux (<LINK REF="REF-Williamson-1993" TYPE="REFERENCE">Williamson 1993</LINK>).</P>
<P>The PPW operation preserves the stomach and the pylorus, the latter of which is needed for the physiologically timed transport of chyme (partially digested food passing into the intestine). This might lead to a more physiologic gastrointestinal passage, but also might lead to higher rates of specific complications such as DGE.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>The extent of resection of the PPW is obviously less than that of the CW operation, therefore it is expected that operation time will decrease and intraoperative blood loss will be less. In addition, some authors report improved postoperative weight gain (<LINK REF="STD-Seiler-2000" TYPE="STUDY">Seiler 2000</LINK>), higher quality of life (<LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>), and better access to the biliary anastomosis for postoperative endoscopy in people with recurrent biliary obstruction. It is unclear whether the lesser extent of the resection is justified from the oncological perspective, and whether DGE occurs more often with the PPW than with the CW operation.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>The objective of this systematic review was to compare the effectiveness of CW and PPW techniques for surgical treatment of cancer of the pancreatic head and the periampullary region.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-02-07 10:27:36 -0500" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Randomised controlled trials (RCTs) irrespective of publication status or language.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>People undergoing an elective PPW or CW operation for periampullary or pancreatic carcinoma.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<UL>
<LI>Pylorus-preserving pancreaticoduodenectomy (PPW).</LI>
<LI>Classic Whipple operation (CW).</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-02-07 10:27:36 -0500" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Postoperative pancreatic-associated morbidity (disease-specific), such as leakage from the pancreatic anastomosis/pancreatic fistula, DGE, and biliary leakage.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-02-07 10:27:36 -0500" MODIFIED_BY="[Empty name]">
<OL>
<LI>Survival.</LI>
<LI>Postoperative mortality.</LI>
<LI>Intraoperative blood loss.</LI>
<LI>Red blood cell transfusion.</LI>
<LI>Operation time.</LI>
<LI>General morbidity, including postoperative gastrointestinal bleeding, wound infection, pulmonary complications, necessity for reoperation.</LI>
<LI>Duration of hospital stay.</LI>
<LI>Quality of life.</LI>
<LI>Status of resection margins (R0/R1* resection).</LI>
</OL>
<P>*R0 means that the tumour is resected without residual microscopic remnants. In an R1 resection, a microscopic remnant of the tumour is present, and in an R2 resection, macroscopic tumour parts can be seen.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-02-05 10:48:35 -0500" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2016-02-05 10:48:35 -0500" MODIFIED_BY="[Empty name]">
<P>We conducted searches on 28 March 2006, 11 January 2011, 9 January 2014, and 18 August 2015 to identify all published and unpublished RCTs, while applying no language restrictions.</P>
<P>We identified relevant trials by searching the following electronic databases on 18 August 2015:</P>
<UL>
<LI>the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR), and the Database of Abstracts of Reviews of Effects (DARE) from the Cochrane Library (2015, Issue 8) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>);</LI>
<LI>MEDLINE (1946 to 18 August 2015) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>); and</LI>
<LI>EMBASE (1980 to 18 August 2015) (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>).</LI>
</UL>
<P>We also handsearched abstracts from the 1995 to 2010 American Digestive Disease Week, published in <I>Gastroenterology</I>, and the United European Gastroenterology Week, published in <I>Gut</I>. After 2011 we no longer updated the handsearch, as it did not contribute any additional relevant information.</P>
<P>We constructed the search strategy for this review by using a combination of medical subject headings (MeSH) and text words related to the use of pancreaticoduodenectomy or pylorus-preserving pancreaticoduodenectomy in the surgical treatment of pancreatic cancer. To identify RCTs, we combined our searches with the Cochrane Highly Sensitive Search Strategy phases one, two, and three, as contained in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (please see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>) (<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We contacted members of the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group and experts in the field and asked them to provide details of outstanding clinical trials and any relevant unpublished or published materials. We furthermore screened reference lists of retrieved trials and used the 'related articles' function in PubMed.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Two review authors independently scanned the abstracts of all trials identified by the search to determine eligibility, selecting full articles for further assessment if the abstract suggested that the trial was relevant. If it was unclear from the abstract whether the article met the inclusion criteria, we retrieved and reviewed the full article for clarification. We excluded papers not meeting our inclusion criteria; we have listed these studies along with reasons for their omission in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table. We resolved any disagreements by discussion with a third review author.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We extracted data from published and unpublished reports using standardised forms. We have presented a list of the data items that we extracted in <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We assessed the methodological quality of the trials. Methodological quality is defined as confidence that the trial design and its report will restrict bias in the comparison of interventions (<LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>). We assessed methodological quality according to the Cochrane 'Risk of bias' tool by examining how the allocation sequence was generated, how allocation concealment was provided, and what risks of other bias were present (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We measured the hazard ratio and determined the 95% confidence interval (CI) for survival. For dichotomous outcomes, we calculated the odds ratio along with 95% CI. For continuous outcomes, we calculated mean difference or standardised mean difference with 95% CI.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2011-02-23 14:22:33 -0500" MODIFIED_BY="[Empty name]">
<P>The unit of analysis was each participant recruited into the trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We performed the analysis on an intention-to-treat basis when possible, otherwise adopting the per-protocol analysis as presented in the original trials.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Using the random-effects model (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>), we calculated pooled estimates of effect and investigated the results for statistical heterogeneity (using the I<SUP>2</SUP> statistic). If we identified an extreme level of heterogeneity, we interpreted summary effect measures with caution. However, we investigated the causes of heterogeneity as far as collected data would allow.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>We used funnel plots to explore publication bias and used asymmetry in a funnel plot of trial size against treatment effect to assess bias (<LINK REF="REF-Egger-1997a" TYPE="REFERENCE">Egger 1997a</LINK>). We created funnel plots for overall survival, postoperative mortality, and the most representative cause of postoperative morbidity, which is occurrence of a pancreatic fistula. We planned a test for asymmetry if we included at least 10 trials in the review, otherwise using funnel plots for inspection and visual detection of potential publication bias only.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>The editorial base and the review authors' host institutions provided additional statistical guidance. We ensured data accuracy by performing double data entry. We combined data from different trials reporting the same or similar comparisons. We summarised dichotomous data using odds ratios, presented continuous data as weighted mean differences, and summarised survival or time-to-event data using hazard ratios (HRs). We calculated pooled HRs and estimated HRs from the data provided in the primary trials according to the methods described by Parmar et al and Tierney et al (<LINK REF="REF-Parmar-1998" TYPE="REFERENCE">Parmar 1998</LINK>; <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK>). If the primary trials provided only median and range, we used the methods described by Hozo et al to calculate mean and standard deviation where appropriate (<LINK REF="REF-Hozo-2005" TYPE="REFERENCE">Hozo 2005</LINK>). We chose the appropriate method according to the sample size of the trial.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<P>We performed subgroup analyses for survival in participants with periampullary cancer or pancreatic head cancer and in both groups together.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-12-29 13:34:44 -0500" MODIFIED_BY="[Empty name]">
<P>We performed sensitivity analysis in cases of differing definitions of outcome measures, analysing trials separately that defined outcome measures identically.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We retrieved 1235 abstracts from the 2006 search, and a further 129 abstracts from the 2011 search, 558 abstracts from the 2014 search, and 413 abstracts from the most recent search update in August 2015. We checked these abstracts for eligibility. The 2006 search produced six randomised controlled trials (RCTs) for inclusion, including data from seven publications, although we identified no additional trials in the 2011 and 2014 searches. The 2015 database search produced no new trials for inclusion in the review. However, we identified two additional trials through other resources during the 2015 update. We handsearched 619 abstracts from Digestive Disease Week and United European Gastroenterology Week (1995 to 2010), but found no additional trials.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Eight RCTs were eligible (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>) (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>). The trial by Lin et al, published in 2005, is an update of the trial performed in 1999; the only data analysed from the older trial involved red blood cell transfusion, because this information was not reported in the later trial (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>). After this and the per-protocol analysis of eight trials were accounted for, the quantitative data from 512 analysed participants comparing PPW (255 participants) and CW (257 participants) procedures were found suitable for the systematic review.</P>
<P>Besides obvious variation in sample sizes (range from 20 in <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK> to 170 in <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), evaluation of trial population baseline characteristics revealed adequate consistency: all analysed participants were included because of resectable pancreatic or periampullary cancer. Moreover, In addition, we observed a similar distribution of positive lymph node status in four trials (mean positive lymph node status was 58.5% (SD = 8.6) in the PPW group and 66.5% (SD = 12.9) in the CW group) (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>).</P>
<P>Regarding perioperative management, we observed non-standardised administration of somatostatin with respect to dosage, route, frequency, and duration. Three of the eight RCTs reported the use of octreotide (100 to 200 µg 3 times per day) (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). No information about the application of erythromycin was available. In the trial by Tran et al (<LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), 10 participants in the CW group and nine in the PPW group received postoperative radiochemotherapy, whereas no participants received adjuvant treatment in one trial by Lin et al (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>). No reports about adjuvant treatment were available for the other trials.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-02-05 10:28:42 -0500" MODIFIED_BY="[Empty name]">
<P>We retrieved 2956 abstracts from the systematic literature search. After screening we excluded 2931 abstracts. Of the remaining 25 abstracts, for which we retrieved the full articles, 16 did not fulfil the inclusion criteria. Most of the excluded articles did not cover surgical aspects of the comparison of PPW and CW, nor did they provide quantitative data on the prespecified outcome parameters. We have presented a study flow diagram in <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>. See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for details.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Our methodological appraisal of the individual trials revealed vast heterogeneity in trial design. Only in the two largest trials (130 participants in <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK> and 170 participants in <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>) was the underlying sample size calculation described. Tran et al stated that at least 65 participants had to be included in each group to show 30% less intraoperative blood loss and a 20% decrease in operation time in the PPW group, with &#945; = 0.05 and &#946; = 0.05 (<LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). The trial authors regarded this number as sufficient to demonstrate a reduction in hospital stay as well. The power calculation in the trial conducted by Seiler et al indicated that 58 participants needed to be enrolled for each procedure to detect a 25% difference in morbidity, with &#945; = 0.05 and &#946; = 0.2 (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>). The number of participants included was not justified in the other six trials (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>).</P>
<P>One trial performed statistical analysis according to the intention-to-treat principle (<LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>); the other trials did not state the analytic principle or were analysed per-protocol.</P>
<P>We assessed publication bias by creating funnel plots for overall survival, postoperative mortality, and pancreatic fistula, the last of which is the most common cause of postoperative morbidity. As fewer than 10 trials were included in all analyses (overall survival N = 3; postoperative mortality N = 7; pancreatic fistula N = 7), we inspected funnel plots for potential publication bias only. We did not observe relevant asymmetry in any plot (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; <LINK REF="FIG-05" TYPE="FIGURE">Figure 5;</LINK> <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>).</P>
<P>'Summary of findings' tables for survival, postoperative mortality, pancreatic fistula, delayed gastric emptying, operating time, intraoperative blood loss, and red blood cell transfusion, created on the basis of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) criteria (<LINK REF="REF-GRADE-2008" TYPE="REFERENCE">GRADE 2008</LINK>), showed low-quality evidence for all of these results except for postoperative mortality, which showed moderate-quality evidence (<LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of results table 3</LINK>).</P>
<ALLOCATION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>None of the trials provided description of the sequence generation process except for <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>, which described a computer-generated sequence generation. <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK> and <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK> described appropriate allocation concealment. None of the other trials provided information about allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>None of the trials reported blinding of the treating physicians, participants, or outcome assessors.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>We evaluated follow-up quality by assessing the follow-up sequence and the duration of follow-up. Three trials reported median follow-up together with a range (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), which varied from 18 months, in <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>, to 63.1 months, in <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>. The trial by Srinarmwong et al described three-monthly follow-up for a minimum of 24 months for all participants up to a maximum of 60 months (<LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>). Four trials provided insufficient information on follow-up (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>). None of the trials reported withdrawals or losses to follow-up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>, <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>, and <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK> provided the most comprehensive definitions for analysed outcomes. The remaining trials did not adequately specify the criteria for the stated endpoints. A published protocol was not available for any of the trials.</P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<P>Data on pancreas-associated morbidity were inconclusive owing to broad ranges for rates of occurrence for pancreatic fistula, delayed gastric emptying, and biliary leakage. For more specific differentiation of the presumed underlying heterogeneity, we performed a meta-analysis of these parameters.</P>
<SUBSECTION>
<HEADING LEVEL="4">Pancreatic fistula</HEADING>
<P>The fistula rate showed no differences between groups: 21 of 232 participants in the PPW group (9.1%) versus 22 of 236 participants in the CW group (9.3%) (OR 0.95, 95% CI 0.49 to 1.84; P = 0.88; I² = 0%). Tran et al defined a pancreatic fistula as drainage of more than 50 ml of amylase-rich fluid per day through surgically placed drains on or after postoperative day 10, or as pancreatic anastomotic disruption demonstrated radiographically (<LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). Similarily, Srinarmwong et al defined a pancreatic fistula as drainage of amylase-rich fluid of more than 50 ml per day persisting after postoperative day 10 (<LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>). Seiler et al defined pancreatic fistula as secretion of 30 ml or more of amylase-rich drainage fluid (more than 5000 units/L) per day for at least 10 days (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>). No definition was given in the other trials (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Although the I² statistic showed no heterogeneity, the pooled results must be regarded with caution owing to the various definitions reported. Butturini et al showed that the incidence of pancreatic fistula varied from 10% to 28.5% within the same group of participants when different common definitions were applied (<LINK REF="REF-Butturini-2006" TYPE="REFERENCE">Butturini 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Delayed gastric emptying (DGE)</HEADING>
<P>Seven trials provided data from 459 participants (229 PPW, 230 CW) on the occurrence of DGE (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). Lin et al and Tran et al used the same definition for DGE (gastric stasis requiring nasogastric intubation for 10 or more days or the inability to tolerate a regular diet on the 14th postoperative day) (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). Srinarmwong et al defined DGE similarly as gastric stasis requiring nasogastric intubation for 10 or more days or the inability to tolerate a regular diet at three months after the operation (<LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>), whereas Seiler et al defined it differently (persistent drainage via the nasogastric tube of more than 500 ml per day for at least five days after surgery, or recurrent vomiting in combination with oedema of the gastrojejunostomy or duodenojejunostomy and proximal dilatation on contrast radiography) (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>). No definition was given in the other trials.</P>
<P>The meta-analysis of all 459 participants revealed a significant benefit for the CW group in terms of DGE, with 72 of 229 participants (31.4%) in the PPW group compared to 54 of 230 (23.5%) in the CW group (OR 3.03, 95% CI 1.05 to 8.70; P = 0.04; I² = 73%) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). Owing to the considerable statistical heterogeneity of 73% in the I² statistic, we performed sensitivity analyses that included trials only according to their definition of DGE, because it is well known that the rate of DGE varies with the underlying definition (<LINK REF="REF-Butturini-2006" TYPE="REFERENCE">Butturini 2006</LINK>).</P>
<P>In contrast, the results of both sensitivity analyses were not significant if only trials with the same definition of DGE were included (OR 4.02, 95% CI 0.14 to 119.16; P = 0.42; I² = 80%) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>), or if all trials that provided any definition of DGE were included (OR 2.00, 95% CI 0.55 to 7.22; P = 0.29; I² = 78%) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>), but the analyses still presented substantial heterogeneity. In the first case, the data for 198 participants were analysed (99 PPW, 99 CW), and in the second case, the data for 355 participants were analysed (177 PPW, 178 CW).</P>
<P>Another factor that could account for the observed heterogeneity might be the different applications of drugs. Participants in three trials received octreotide (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), whereas no participants in the trial by Lin et al were treated with octreotide (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>). No statement about the application of octreotide was provided for the remaining trials (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>). None of the trials provided information on the application of prokinetic drugs such as erythromycin or metoclopramide. Owing to these restrictions, the above-mentioned pooled results must be regarded with caution. Five trials favoured CW (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>), and two trials reported comparable rates for DGE (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Biliary leakage</HEADING>
<P>The summarised effect size of five RCTs comparing biliary leakage after PPW and CW showed no differences between the groups (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>): 5 of 191 (2.6%) in the PPW group versus 4 of 198 (2.0%) in the CW group (OR 0.96, 95% CI 0.15 to 6.17; P = 0.96; I² = 37%) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary Outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Survival</HEADING>
<P>Four trials provided survival data suitable for the meta-analysis (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>): long-term results (60 months in <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>, <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>, and <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>, and 36 months in <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>, actuarial Kaplan-Meier analysis) from a total of 317 participants (152 PPW, 165 CW) were evaluated by comparing hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) using the random-effects model. We calculated HRs from survival rates at different time points, as they were given in the Kaplan-Meier curves according to the methods described by Parmar et al and Tierney et al (<LINK REF="REF-Parmar-1998" TYPE="REFERENCE">Parmar 1998</LINK>; <LINK REF="REF-Tierney-2007" TYPE="REFERENCE">Tierney 2007</LINK>). Three trials presented Kaplan-Meier curves for periampullary and pancreatic head carcinoma together (<LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). This analysis was based on the data provided for 284 participants (138 PPW, 146 CW). No significant differences could be observed in the pooled results (HR 0.84, 95% CI 0.61 to 1.16; P = 0.29; I² = 9%) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>).</P>
<P>Three trials with 203 participants (98 PPW, 105 CW) presented Kaplan-Meier curves for those with pancreatic head carcinoma (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). Pooled results revealed no significant differences in survival (HR 0.73, 95% CI 0.43 to 1.22; P = 0.23; I² = 62%) (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
<P>Two trials with 74 participants (37 PPW, 37 CW) presented Kaplan-Meier curves for periampullary carcinoma (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), but the pooled HR showed no significant difference in survival between the groups (HR 0.83, 95% CI 0.39 to 1.76; P = 0.63; I² = 0%) (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>).</P>
<P>The trial by Srinarmwong et al provided actual one- and two-year survival rates, which showed no significant differences between the PPW and CW groups. However, as information needed to calculate HRs was insufficient, we could not incorporate these results in the meta-analyses concerning survival.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Postoperative mortality</HEADING>
<P>Postoperative mortality showed similar ranges in the PPW group (0% in <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK> to 28.6% in <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>) and the CW group (0% in <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK> and <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK> to 15.4% in <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>). The overall effect estimate of 231 (PPW) versus 233 (CW) participants revealed no significant differences in postoperative mortality (odds ratio (OR) 0.64, 95% CI 0.26 to 1.54; P = 0.32; I² = 0%) (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Perioperative parameters</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Intraoperative blood loss</HEADING>
<P>The amount of intraoperative blood loss was analysed in 404 participants (202 PPW, 202 CW) of five trials (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). Intraoperative blood loss was significantly reduced in the PPW compared to the CW group (MD -0.32, 95% CI -0.62 to -0.03; P = 0.03; I² = 83%) (<LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Red blood cell transfusion</HEADING>
<P>Correspondingly, the summarised effect estimate of blood replacement (units) indicated a significantly reduced application of blood products in the PPW group (MD -0.47, 95% CI -0.86 to -0.07; P = 0.02; I² = 0%) (<LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>). This result was based on data from 273 participants in five trials (139 PPW, 134 CW) (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Operating time</HEADING>
<P>A meta-analysis of operating time for seven RCTs demonstrated a significant reduction in operating time (minutes) for the PPW operation (mean difference (MD) -45.22, 95% CI -74.67 to -15.78; P = 0.003; I² = 84%) (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>). This analysis was based on data from 472 participants (238 PPW, 234 CW) (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Postoperative bleeding</HEADING>
<P>Five trials evaluated postoperative bleeding (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). Ten of 191 participants (5.2%) in the PPW group and 13 of 189 participants (6.9%) in the CW group were identified; this finding was not statistically significant (OR 0.74, 95% CI 0.32 to 1.74; P = 0.50; I² = 0%) (<LINK REF="CMP-009.01" TYPE="ANALYSIS">Analysis 9.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Wound infection</HEADING>
<P>Wound infection yielded no statistically significant differences, occurring in 10 of 119 participants in the PPW group (8.4%) and in 13 of 132 participants in the CW group (9.8%) (OR 0.85, 95% CI 0.35 to 2.05; P = 0.72; I² = 0%) (<LINK REF="CMP-010.01" TYPE="ANALYSIS">Analysis 10.1</LINK>). Four trials reported incidences of wound infection but without definition (<LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pulmonary complications</HEADING>
<P>Three trials reported pulmonary complications. We analysed data for 218 participants (105 PPW, 113 CW). Wenger et al and Paquet et al specified pulmonary complications as pneumonia (<LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>), and Seiler et al referred to pulmonary complications as "pulmonary morbidity" (<LINK REF="STD-Seiler-2000" TYPE="STUDY">Seiler 2000</LINK>). We could identify no significant differences between PPW and CW groups (OR 0.67, 95% CI 0.29 to 1.58; P = 0.36; I² = 0%) (<LINK REF="CMP-011.01" TYPE="ANALYSIS">Analysis 11.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Necessity for reoperation</HEADING>
<P>Three trials reported this outcome (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). In total, 16 of 163 participants in the PPW group (9.8%) and 18 of 157 participants in the CW group (11.5%) required reoperation. This result did not show statistical significance (OR 0.80, 95% CI 0.38 to 1.68; P = 0.56; I² = 0%) (<LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Duration of hospital stay</HEADING>
<P>The duration of hospital stay (days) showed similar results between groups (MD 0.26, 95% CI -2.04 to 2.56; P = 0.82; I² = 0%) in a meta-analysis of five trials evaluating a total of 366 participants (188 in the PPW group and 178 in the CW group) (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>) (<LINK REF="CMP-013.01" TYPE="ANALYSIS">Analysis 13.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Quality of life (QoL)</HEADING>
<P>Owing to the use of different QoL questionnaires, it was impossible to pool these data quantitatively. We thus presented a qualitative overview of QoL results by operative procedure.</P>
<P>Three RCTs reported outcomes for QoL (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>). <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK> and <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK> used the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-30 questionnaire in their RCTs, but only Wenger et al used the recommended pancreas-specific module QLQ-PAN 26 (<LINK REF="REF-Fitzsimmons-1998" TYPE="REFERENCE">Fitzsimmons 1998</LINK>). The data from each RCT showed no significant differences in overall QoL by procedure.</P>
<P>In the trial by Wenger et al, QoL was assessed preoperatively and after 2, 4, 6, 24, 36, 48, and 60 weeks. Participants in the PPW group scored significantly better on the domains loss of appetite, nausea and vomiting, diarrhoea, and weight gain. No significant difference in overall QoL was noted (<LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>).</P>
<P>Bloechle et al did not specify the assessment time points but, like Wenger, reported a significantly better score for participants in the PPW group in the domains loss of appetite and weight gain, but no difference in overall QoL, diarrhoea, nausea and vomiting (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>).</P>
<P>Seiler et al assessed QoL preoperatively using the Sickness Impact Profile and again after 6, 12, 18, and 24 months. This group found no differences in postoperative weight gain or overall QoL, but did report that ability to work after six months was better for participants in the PPW group than for those in the CW group (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Status of resection margins (R0/R1* resection)</HEADING>
<P>Four trials provided data on resection margin status after PPW or CW, respectively (<LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>): all four trials showed a balanced interstudy and intrastudy distribution of R0 resections (resections without microscopical tumour remnants) with an overall R0 resection rate of 80.2% (142 of 177 participants) in the PPW group and 81.9% (149 of 182 participants) in the CW group. The meta-analytic result was not statistically significant (OR 0.92, 95% CI 0.39 to 2.15; P = 0.84; I² = 0%) (<LINK REF="CMP-014.01" TYPE="ANALYSIS">Analysis 14.1</LINK>).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>For the past decades preservation of the pylorus in people undergoing partial pancreaticoduodenectomy for cancer has been a controversial issue. Numerous studies have been performed, including several randomised controlled trials (RCTs), but the cumulative knowledge gained from these needed to be captured in a quantitative summary of the results to establish whether or not pylorus-preserving pancreaticoduodenectomy (PPW) is a better technique than the classic Whipple (CW) operation.</P>
<P>We could find no evidence of superiority of one procedure over the other from a curative perspective in this systematic review and meta-analysis. Pooled long-term results of four RCTs showed no differences in terms of overall survival (hazard ratio (HR) 0.84; P = 0.29).</P>
<P>Differences in postoperative mortality between the two techniques were not statistically significant. As for surgical and clinically relevant parameters of morbidity, we found no significant differences for the occurrence of pancreatic fistula (odds ratio (OR) 0.95; P = 0.88), biliary leakage (OR 0.96; P = 0.96), or postoperative bleeding (OR 0.74; P = 0.50). The analysis of delayed gastric emptying (DGE) showed a significant reduction of this complication in the CW group (OR 3.03; P = 0.04), but the sensitivity analyses regarding the definitions of DGE did not corroborate this finding.</P>
<P>The PPW procedure showed several significant benefits in perioperative outcome measures such as operating time (mean difference (MD) -45.22 min; P = 0.003), intraoperative blood loss (MD -0.32 L; P = 0.03), and red blood cell transfusion (MD -0.47 units; P = 0.02). Shorter operating time is an advantage of the PPW operation in terms of cost, but the benefits of this reduced operating time for postoperative morbidity (for example pulmonary and cardiac complications) are unclear. Also, the reduction in intraoperative blood loss and blood transfusion seems not to impact postoperative morbidity and mortality. Furthermore, length of hospital stay was not significantly different between the two groups (MD 0.26 days; P = 0.82). The analyses on perioperative outcomes and length of hospital stay must be interpreted with caution as substantial heterogeneity (greater than 70%) was present in some of these analyses, and the estimated means and standard deviations might not be reliable due to a skewed distribution of the primary data.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Our findings are in line with those of a recently published study from Bassi et al (<LINK REF="REF-Bassi-2005a" TYPE="REFERENCE">Bassi 2005a</LINK>), in which survival data were correlated with type of surgery by multivariate analysis. These results indicated that neither the type of surgery (PPW versus CW; HR 0.8; P = 0.078) nor the occurrence of postoperative complications significantly affected the hazard of death once tumour staging was taken into account (grade, nodal status, and maximum tumour size). As shown by Neoptolemos et al (<LINK REF="REF-Neoptolemos-2001" TYPE="REFERENCE">Neoptolemos 2001</LINK>), it was not resection margin status R0/R1 but rather tumour grade and lymph node status that were by far the most powerful prognostic factors of survival.</P>
<P>In terms of DGE, previous reports of non-randomised cohort studies reporting higher rates after the PPW procedure were confirmed by the results of our meta-analysis (<LINK REF="REF-Mosca-1997" TYPE="REFERENCE">Mosca 1997</LINK>; <LINK REF="REF-Roder-1992" TYPE="REFERENCE">Roder 1992</LINK>). However, five of the eight included trials showing higher rates of DGE in the PPW group all had small sample sizes (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>), with a maximum of 44 participants in one trial (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>). Given that a significant difference for the occurrence of DGE was found only when all included trials were considered (31.4% PPW versus 23.9% CW; OR 3.03; P = 0.04) and that there was no significant difference in the sensitivity analyses according to the definition of DGE, these results reinforce the importance of well-defined endpoints in surgical trials and furthermore indicate that underpowered studies potentially overestimate the benefits of CW for the outcome of DGE (<LINK REF="REF-Butturini-2006" TYPE="REFERENCE">Butturini 2006</LINK>; <LINK REF="REF-Kunz-1998" TYPE="REFERENCE">Kunz 1998</LINK>).</P>
<P>If PPW and CW are equally effective regarding survival, postoperative mortality, and morbidity, quality of life (QoL) could become the crucial factor in comparisons between the two procedures. Although three of the eight trials reported QoL as an outcome, we could reach no conclusion because the trials used different questionnaires administered at different time points, and only sparse information assessing QoL was available in the trial by Bloechle et al (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Given obvious sources of potential bias in the included trials such as small sample sizes, varying or missing definitions of outcome parameters, the lack of blinding, and inexplicit methods of randomisation and allocation concealment, our results should be interpreted with caution. We observed no clear differences between PPW and CW techniques for survival, postoperative mortality, or main complications. Much larger and more rigorously designed trials than are currently available would be needed to demonstrate potential superiority of one or the other technique. This highlights the urgent need for the development of standardised RCTs for complex interventions. Moreover, these trials should rely on evidence-based consensus definitions of surgical interventions and their outcome parameters.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Systematic reviews currently provide the best method of summarising existing evidence, but the quality of such reviews depends on the quality of the primary studies (<LINK REF="REF-Egger-1997b" TYPE="REFERENCE">Egger 1997b</LINK>; <LINK REF="REF-Mulrow-1994" TYPE="REFERENCE">Mulrow 1994</LINK>). Thus, the trials included in this review are partially marred by bias and clinical heterogeneity, and this may distort results.</P>
<P>Our Cochrane Highly Sensitive Search Strategy was approved by an expert in the field (GA), but it may still be biased. In an attempt to identify all relevant trials, we contacted experts in pancreatic surgery and in clinical research to identify additional or ongoing trials. We identified two additional relevant trials by this procedure.</P>
<P>The fact that the randomisation process was carried out differently in the reviewed trials can be considered as a source of bias, because adequate randomisation and allocation concealment generate balanced groups for known, unknown, and unmeasured confounders. Only one of the included trials provided adequate descriptions of the random sequence generation process (<LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>), whereas the other trials failed to describe the method of sequence generation satisfactorily.</P>
<P>Moreover, only two trials specified maintenance of allocation concealment and blinding of the outcome assessor (<LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>).</P>
<P>In addition, median follow-up and follow-up sequences varied significantly between individual trials (median follow-up 18 months in <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK> to 144 months in <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>). This insufficient reporting on inconsistent follow-up sequences is a possible indicator of performance bias.</P>
<P>Furthermore, we found varying or even missing definitions of surrogate parameters such as pancreatic fistula and DGE. The trials by Seiler et al, Srinarmwong et al, and Tran et al provided the most comprehensive definitions (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>). The other trials did not specify the criteria of their endpoints at all. The heterogeneous definitions of outcome parameters may have caused detection bias.</P>
<P>Internationally accepted scaled definitions for surgical outcome parameters in pancreatic cancer surgery have been introduced in recent years. Efforts such as the consensus conference of the International Study Group for Definition of Postoperative Pancreatic Fistula, Post-Pancreatectomy Haemorrhage and DGE should be encouraged, to decrease interobserver variability (<LINK REF="REF-Bassi-2005b" TYPE="REFERENCE">Bassi 2005b</LINK>; <LINK REF="REF-Wente-2007a" TYPE="REFERENCE">Wente 2007a</LINK>; <LINK REF="REF-Wente-2007b" TYPE="REFERENCE">Wente 2007b</LINK>).</P>
<P>Regarding the use of antibiotics, somatostatin, drains, nasogastric tubes, etc., we observed a non-standardised therapeutic concept or even non-reporting with respect to dosage, route, frequency, and duration of administration. The considerable variation in perioperative management is thus a further indicator of interstudy heterogeneity, and this may influence the external validity of the summarised results.</P>
<P>Another possible source of bias lies in the statistical analysis. Only one trial used an intention-to-treat approach (<LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), whereas the remaining trials applied per-protocol analysis or did not specify their analysis approach. This distorted analysis of participants lost to follow-up or missing information on excluded participants (attrition bias) makes it difficult to decide whether the remaining study population is representative (external validity). Moreover, statistical analysis of obviously underpowered trials (six trials, <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>, <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>, <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>, <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>, <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>, and <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>, represent only ~40% of the total number of participants) reduces the explanatory power of these results, since small studies are known to potentially bias treatment effects (<LINK REF="REF-Kunz-1998" TYPE="REFERENCE">Kunz 1998</LINK>). A power calculation was reported for only two trials (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>), and some of the results may not reach statistical significance owing to the lack of an appropriate number of participants.</P>
<P>In this context, we should point out that we did not investigate the influence of neoadjuvant and adjuvant treatment because relevant data were not reported in an interpretable way in the reviewed trials. Our results may therefore be biased, because adjuvant treatment (for example chemotherapy, chemoradiation) represents a possible confounder with an impact on survival, postoperative mortality, and morbidity.</P>
<P>In spite of the sources of clinical and methodological heterogeneity already mentioned, we still observed adequately balanced groups when we compared interstudy baseline population characteristics: all analysed participants were included because of suspected pancreatic or periampullary carcinoma. Our systematic review also revealed a balanced distribution of R0/R1 resections (mean R0 resection: 91.1% PPW, 90.4% CW) and lymph node status (mean positive lymph node status: 58.5% PPW, 66.5% CW). The calculated average level of statistical heterogeneity of all 15 meta-analytical approaches indicated moderate heterogeneity of 22.8% (I² statistic). Nevertheless, given obvious sources of clinical and methodological heterogeneity, we decided to compute the statistics of our meta-analysis using the random-effects model, which allows for variation in the treatment effects of individual studies while providing a more conservative pooled effect estimate (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>).</P>
<P>Given the obvious sources of bias, the results of our systematic review and meta-analyses must be interpreted with caution. Small sample size, missing definitions of outcome parameters, and inexplicit randomisation and allocation concealment are some of the most relevant factors that can produce misleading results.</P>
<P>Eight trials providing high-level evidence addressing identical surgical problems produced many examples of clinically relevant heterogeneity. This calls for future efforts to overcome current hurdles to achieving standardised RCTs for complex interventions. Moreover, evidence-based consensus is mandatory to establish refined definitions for surgical interventions and their putative outcome parameters. This systematic review and meta-analysis of the PPW versus the CW procedure could serve as an ideal basis for the pursuit of such endeavours.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>This review agrees with the conclusions of the authors of all included trials (<LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>; <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>; <LINK REF="STD-Paquet-1998" TYPE="STUDY">Paquet 1998</LINK>; <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>; <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK>; <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>; <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>; <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK>). It also agrees with the findings of a systematic review and meta-analysis of randomised trials on this topic (<LINK TAG="OTHER_VERSIONS_REFERENCES" TYPE="SECTION">Other published versions of this review</LINK>). Our results differ slightly from the systematic reviews of Iqbal et al and Karanicolas et al (<LINK REF="REF-Iqbal-2008" TYPE="REFERENCE">Iqbal 2008</LINK>; <LINK REF="REF-Karanicolas-2007" TYPE="REFERENCE">Karanicolas 2007</LINK>), which might be explained by our inclusion of two novel trials, <LINK REF="STD-Srinarmwong-2008" TYPE="STUDY">Srinarmwong 2008</LINK> and <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>, that were not available at the time of the former reviews. Furthermore, Iqbal et al included a number of non-randomised studies, which could have introduced bias into their results (<LINK REF="REF-Iqbal-2008" TYPE="REFERENCE">Iqbal 2008</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>In conclusion, current evidence on the basis of existing RCTs suggests no difference between the PPW and the CW operation in terms of survival, postoperative mortality, and main morbidity. There might be a potential benefit for the CW operation in terms of delayed gastric emptying, but sensitivity analyses could not corroborate this finding. However, it does appear that the PPW procedure may reduce operating time, intraoperative blood loss, and red blood cell transfusion.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Much larger and more rigorously designed trials than those currently available are needed to demonstrate further differences between these two procedures. The ideal future trial would be a non-inferiority (thousands of participants) multicentre RCT, which hardly seems feasible owing to the present lack of funding in this field.</P>
<P>Some trials have been started concerning a novel method of a pylorus-resecting pancreaticoduodenectomy, in which the stomach is completely preserved, but the pyloric ring is resected (<LINK REF="REF-Hackert-2013" TYPE="REFERENCE">Hackert 2013</LINK>; <LINK REF="REF-Kawai-2011" TYPE="REFERENCE">Kawai 2011</LINK>). This novel technique might combine the positive effects of the CW (less delayed gastric emptying) with those of the PPW (shorter operating time, less intraoperative blood loss and blood transfusion), but high-quality evidence is still lacking for this procedure.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>This review was carried out on the basis of a systematic review and meta-analysis published elsewhere (<LINK REF="REF-Diener-2007" TYPE="REFERENCE">Diener 2007</LINK>).</P>
<P>Christina Fitzmaurice holds a T32 NIH training grant (United States of America).</P>
<P>We thank Professor Dr Hanns-Peter Knaebel for his contribution to the design and conduct of the formerly published versions of this review. He has since become Chief Executive Officer of Aesculap AG, a medical device company that produces surgical instruments, and as such is now in breach of Cochrane's commercial sponsorship policy. He is therefore no longer an author of the current and subsequent versions of this Cochrane review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>MKD: none known.</P>
<P>CF: holds a T32 NIH training grant (United States of America).</P>
<P>GS: none known.</P>
<P>CMS: none known.</P>
<P>FJH: none known.</P>
<P>GA: none known.</P>
<P>MWB: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-02-05 10:34:59 -0500" MODIFIED_BY="[Empty name]">
<P>MKD:</P>
<UL>
<LI>Designing the review.</LI>
<LI>Collecting data for the review.</LI>
<LI>Undertaking searches.</LI>
<LI>Screening search results.</LI>
<LI>Organising retrieval of papers.</LI>
<LI>Screening retrieved papers against inclusion criteria.</LI>
<LI>Appraising quality of papers.</LI>
<LI>Extracting data from papers.</LI>
<LI>Writing to authors of papers to ask for additional information.</LI>
<LI>Providing additional data about papers.</LI>
<LI>Obtaining and screening data on unpublished studies.</LI>
<LI>Managing data for the review.</LI>
<LI>Entering data into <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>.</LI>
<LI>Analysing data.</LI>
<LI>Interpreting data.</LI>
<LI>Providing a methodological perspective.</LI>
<LI>Providing a clinical perspective.</LI>
<LI>Providing a consumer perspective.</LI>
<LI>Writing the review.</LI>
<LI>Performing previous work that served as the foundation of the current study.</LI>
</UL>
<P>CF:</P>
<UL>
<LI>Collecting data for the review.</LI>
<LI>Designing search strategies.</LI>
<LI>Undertaking searches.</LI>
<LI>Screening search results.</LI>
<LI>Organising retrieval of papers.</LI>
<LI>Screening retrieved papers against inclusion criteria.</LI>
<LI>Appraising quality of papers.</LI>
<LI>Extracting data from papers.</LI>
<LI>Writing to authors of papers to ask for additional information.</LI>
<LI>Providing additional data about papers.</LI>
<LI>Obtaining and screening data on unpublished studies.</LI>
<LI>Managing data for the review.</LI>
<LI>Entering data into <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>.</LI>
<LI>Analysing data.</LI>
<LI>Interpreting data.</LI>
<LI>Writing the review.</LI>
<LI>Revising the review after peer review.</LI>
</UL>
<P>GS:</P>
<UL>
<LI>Extracting data from papers.</LI>
<LI>Analysing data.</LI>
<LI>Interpreting data.</LI>
</UL>
<P>CMS:</P>
<UL>
<LI>Providing a methodological perspective.</LI>
<LI>Providing general advice on the review.</LI>
<LI>Interpreting the data.</LI>
<LI>Providing a clinical perspective.</LI>
<LI>Providing a policy perspective.</LI>
</UL>
<P>FJH:</P>
<UL>
<LI>Collecting data for the review.</LI>
<LI>Undertaking searches.</LI>
<LI>Screening search results.</LI>
<LI>Organising retrieval of papers.</LI>
<LI>Screening retrieved papers against inclusion criteria.</LI>
<LI>Appraising quality of papers.</LI>
<LI>Extracting data from papers.</LI>
<LI>Writing to authors of papers to ask for additional information.</LI>
<LI>Providing additional data about papers.</LI>
<LI>Obtaining and screening data on unpublished studies.</LI>
<LI>Managing data for the review.</LI>
<LI>Entering data into <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>.</LI>
<LI>Analysing data.</LI>
<LI>Interpreting data.</LI>
<LI>Providing a clinical perspective.</LI>
<LI>Updating the review.</LI>
<LI>Writing the updated review.</LI>
</UL>
<P>GA:</P>
<UL>
<LI>Providing a methodological perspective.</LI>
<LI>Providing general advice on the review.</LI>
</UL>
<P>MWB:</P>
<UL>
<LI>Providing a clinical perspective.</LI>
<LI>Providing a policy perspective.</LI>
<LI>Providing general advice on the review.</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>The review differs in five points from the previously published protocol.</P>
<UL>
<LI>We combined the outcomes of postoperative bleeding and postoperative gastrointestinal bleeding.</LI>
<LI>We discarded the outcomes of intra-abdominal fluid collection/abscess, duration of intensive care unit stay, early and late dumping, postoperative reflux, number and status of removed lymph nodes, shock, sepsis, renal failure, weight loss, and endocrine and exocrine insufficiency because no usable data were available.</LI>
<LI>We performed an additional quality assessment on the basis of a checklist developed by Downs et al (<LINK REF="REF-Downs-1998" TYPE="REFERENCE">Downs 1998</LINK>).</LI>
<LI>We performed a subgroup analysis for pancreatic head cancer and periampullary cancer for survival.</LI>
<LI>We performed a sensitivity analysis for delayed gastric emptying by using different definitions.</LI>
<LI>We calculated means and standard deviations according to the methods by Hozo et al for trials that provided only medians and ranges (<LINK REF="REF-Hozo-2005" TYPE="REFERENCE">Hozo 2005</LINK>).</LI>
</UL>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2015-12-28 08:46:01 -0500" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-02-05 10:48:43 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2016-02-05 02:24:35 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-02-05 02:24:35 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bloechle-1999" MODIFIED="2008-05-09 12:10:53 -0400" MODIFIED_BY="[Empty name]" NAME="Bloechle 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-05-09 12:10:53 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bloechle C, Broering DC, Latuske C</AU>
<TI>Prospective randomized study to evaluate quality of life after partial pancreatoduodenectomy according to Whipple versus pylorus preserving pancreatoduodenectomy according to Longmire-Traverso for periampullary carcinoma</TI>
<SO>Deutsche Gesellschaft für Chirurgie</SO>
<YR>1999</YR>
<VL>Supplement 1, Forumband</VL>
<PG>661-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-05-07 20:44:44 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lin-1999" MODIFIED="2011-03-10 12:31:54 -0500" MODIFIED_BY="Karin L Dearness" NAME="Lin 1999" YEAR="2005">
<REFERENCE MODIFIED="2011-03-10 12:31:54 -0500" MODIFIED_BY="Karin L Dearness" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lin PW, Lin YJ</AU>
<TI>Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy</TI>
<SO>British Journal of Surgery</SO>
<YR>1999</YR>
<VL>86</VL>
<NO>5</NO>
<PG>603-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lin PW, Shan YS, Lin YJ, Hung CJ</AU>
<TI>Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure</TI>
<SO>Hepatogastroenterology</SO>
<YR>2005</YR>
<VL>52</VL>
<NO>65</NO>
<PG>1601-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paquet-1998" MODIFIED="2016-02-05 02:21:51 -0500" MODIFIED_BY="[Empty name]" NAME="Paquet 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-02-05 02:21:51 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paquet K-J</AU>
<TI>Comparison of Whipple's pancreaticoduodenectomy with the pylorus-preserving pancreaticoduodenectomy - a prospectively controlled, randomized long-term trial</TI>
<TO>Vergleich der partiellen Duodenopankreatektomie (Whipple-Operation) mit der pyloruserhaltenden Zephaloduodenopankreatektomie - eine prospektive kontrollierte, randomisierte Langzeitstudie</TO>
<SO>Chirurgische Gastroenterologie</SO>
<YR>1998</YR>
<VL>14</VL>
<PG>54-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seiler-2005" MODIFIED="2016-02-05 02:22:35 -0500" MODIFIED_BY="[Empty name]" NAME="Seiler 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-02-05 02:22:35 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Seiler CA, Wagner M, Bachmann T, Redaelli CA, Schmied B, Uhl W et al</AU>
<TI>Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection - long term results</TI>
<SO>British Journal of Surgery</SO>
<YR>2005</YR>
<VL>92</VL>
<NO>5</NO>
<PG>547-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Srinarmwong-2008" MODIFIED="2016-02-05 02:23:28 -0500" MODIFIED_BY="[Empty name]" NAME="Srinarmwong 2008" YEAR="2008">
<REFERENCE MODIFIED="2016-02-05 02:23:28 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Srinarmwong C, Luechakiettisak P, Prasitvilai W</AU>
<TI>Standard Whipple's operation versus pylorus preserving pancreaticoduodenectomy: a randomized controlled trial study</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2008</YR>
<VL>91</VL>
<NO>5</NO>
<PG>693-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-12-01 06:45:52 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taher-2015" MODIFIED="2016-02-05 02:24:35 -0500" MODIFIED_BY="[Empty name]" NAME="Taher 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-02-05 02:24:35 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taher MA, Khan ZR, Chowdhury MM, Nur-E-Elahi M, Chowdhury AK, Faruque MS et al</AU>
<TI>Pylorus preserving pancreaticoduodenectomy vs. standard Whipple's procedure in case of carcinoma head of the pancreas and periampullary carcinoma</TI>
<SO>Mymensingh Medical Journal</SO>
<YR>2015</YR>
<VL>24</VL>
<NO>2</NO>
<PG>319-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tran-2004" NAME="Tran 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tran KT, Smeenk HG, van Eijck CH, Kazemier G, Hop WC, Greve JW et al</AU>
<TI>Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors</TI>
<SO>Annals of Surgery</SO>
<YR>2004</YR>
<VL>240</VL>
<NO>5</NO>
<PG>738-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wenger-1999" MODIFIED="2011-03-08 08:07:56 -0500" MODIFIED_BY="[Empty name]" NAME="Wenger 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-03-08 08:07:56 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM</AU>
<TI>Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy</TI>
<SO>Chirurg</SO>
<YR>1999</YR>
<VL>70</VL>
<PG>1454-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bakkevold-1993" MODIFIED="2008-05-09 12:17:16 -0400" MODIFIED_BY="[Empty name]" NAME="Bakkevold 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-05-09 12:17:16 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bakkevold KE, Kambestad B</AU>
<TI>Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results</TI>
<SO>Annals of Surgery</SO>
<YR>1993</YR>
<VL>217</VL>
<NO>4</NO>
<PG>356-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bassi-1994" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Bassi 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bassi C, Falconi M, Lobardi D, Briani G, Vesentini S, Camboni MG et al</AU>
<TI>Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group</TI>
<SO>Digestion</SO>
<YR>1994</YR>
<VL>55</VL>
<NO>Suppl 1</NO>
<PG>41-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bell-2005" MODIFIED="2008-05-09 12:17:37 -0400" MODIFIED_BY="[Empty name]" NAME="Bell 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-05-09 12:17:37 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bell RH Jr</AU>
<TI>Pancreaticoduodenectomy with or without pylorus preservation have similar outcomes</TI>
<SO>Cancer Treatment Reviews</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>4</NO>
<PG>328-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brennan-1994" MODIFIED="2008-05-09 12:17:52 -0400" MODIFIED_BY="[Empty name]" NAME="Brennan 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-05-09 12:17:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brennan MF, Pisters PW, Posner M, Quesada O, Shike M</AU>
<TI>A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy</TI>
<SO>Annals of Surgery</SO>
<YR>1994</YR>
<VL>220</VL>
<NO>4</NO>
<PG>436-41; discussion 441-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buchler-1993" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" NAME="Buchler 1993" YEAR="1993">
<REFERENCE MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buchler M, Friess H</AU>
<TI>Prevention of postoperative complications following pancreatic surgery</TI>
<SO>Digestion</SO>
<YR>1993</YR>
<VL>54(Suppl 1)</VL>
<PG>41-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chou-1996" MODIFIED="2008-05-09 12:18:56 -0400" MODIFIED_BY="[Empty name]" NAME="Chou 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-05-09 12:18:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL</AU>
<TI>Postoperative morbidity and mortality of pancreaticoduodenectomy for periampullary cancer</TI>
<SO>European Journal of Surgery</SO>
<YR>1996</YR>
<VL>162</VL>
<NO>6</NO>
<PG>477-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farnell-2005" MODIFIED="2008-05-09 12:19:18 -0400" MODIFIED_BY="[Empty name]" NAME="Farnell 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-05-09 12:19:18 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;CORPORATE NAME: Pancreas Cancer Working Group.&lt;/p&gt;" NOTES_MODIFIED="2008-05-09 12:19:18 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR et al</AU>
<TI>A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma</TI>
<SO>Surgery</SO>
<YR>2005</YR>
<VL>138</VL>
<NO>4</NO>
<PG>618-28; discussion 628-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friess-1996" MODIFIED="2008-05-09 12:19:30 -0400" MODIFIED_BY="[Empty name]" NAME="Friess 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-05-09 12:19:30 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Friess H, Berberat P, Schilling M, Kunz J, Korc M, Buchler MW</AU>
<TI>Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors</TI>
<SO>Journal of Molecular Medicine</SO>
<YR>1996</YR>
<VL>74</VL>
<NO>1</NO>
<PG>35-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnstone-1993" MODIFIED="2008-05-09 12:19:43 -0400" MODIFIED_BY="[Empty name]" NAME="Johnstone 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-05-09 12:19:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnstone PA, Sindelar WF</AU>
<TI>Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial</TI>
<SO>Pancreas</SO>
<YR>1993</YR>
<VL>8</VL>
<NO>5</NO>
<PG>535-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nguyen-2003" MODIFIED="2008-05-09 12:19:57 -0400" MODIFIED_BY="[Empty name]" NAME="Nguyen 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-05-09 12:19:57 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA, Coleman J et al</AU>
<TI>Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>1</NO>
<PG>1-9; discussion 9-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pedrazzoli-1998" MODIFIED="2008-05-09 12:20:11 -0400" MODIFIED_BY="[Empty name]" NAME="Pedrazzoli 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-05-09 12:20:11 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C et al</AU>
<TI>Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group</TI>
<SO>Annals of Surgery</SO>
<YR>1998</YR>
<VL>228</VL>
<NO>4</NO>
<PG>508-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seiler-2000" MODIFIED="2011-02-22 13:37:16 -0500" MODIFIED_BY="Karin L Dearness" NAME="Seiler 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-02-22 13:37:16 -0500" MODIFIED_BY="Karin L Dearness" NOTES="&lt;p&gt;DA - 20001130&lt;/p&gt;" NOTES_MODIFIED="2011-02-22 13:37:16 -0500" NOTES_MODIFIED_BY="Karin L Dearness" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Seiler CA, Wagner M, Sadowski C, Kulli C, Buchler MW</AU>
<TI>Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>5</NO>
<PG>443-52</PG>
<IDENTIFIERS MODIFIED="2011-02-22 13:37:16 -0500" MODIFIED_BY="Karin L Dearness">
<IDENTIFIER MODIFIED="2011-02-22 13:37:16 -0500" MODIFIED_BY="Karin L Dearness" TYPE="PUBMED" VALUE="11077317"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shan-2003" MODIFIED="2011-03-08 08:08:38 -0500" MODIFIED_BY="[Empty name]" NAME="Shan 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-03-08 08:08:38 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shan YS, Sy ED, Lin PW</AU>
<TI>Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial</TI>
<SO>World Journal of Surgery</SO>
<YR>2003</YR>
<VL>27</VL>
<NO>6</NO>
<PG>709-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Berge-Henegouwen" MODIFIED="2008-05-09 12:21:03 -0400" MODIFIED_BY="[Empty name]" NAME="van Berge Henegouwen" YEAR="1998">
<REFERENCE MODIFIED="2008-05-09 12:21:03 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Berge Henegouwen MI, Moojen TM, van Gulik TM, Rauws EA, Obertop H, Gouma DJ</AU>
<TI>Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status</TI>
<SO>British Journal of Surgery</SO>
<YR>1998</YR>
<VL>85</VL>
<NO>7</NO>
<PG>922-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wagner-2004" MODIFIED="2008-05-09 12:21:08 -0400" MODIFIED_BY="[Empty name]" NAME="Wagner 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-05-09 12:21:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW</AU>
<TI>Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma</TI>
<SO>British Journal of Surgery</SO>
<YR>2004</YR>
<VL>91</VL>
<NO>5</NO>
<PG>586-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yeo-1999" MODIFIED="2008-05-14 09:17:04 -0400" MODIFIED_BY="Cathy Bennett" NAME="Yeo 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-05-14 09:17:04 -0400" MODIFIED_BY="Cathy Bennett" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH et al</AU>
<TI>Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome</TI>
<SO>Annals of Surgery</SO>
<YR>1999</YR>
<VL>229</VL>
<NO>5</NO>
<PG>613-22; discussion 622-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-02-05 10:48:43 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2016-02-05 10:48:43 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bassi-2001" MODIFIED="2008-05-09 12:24:30 -0400" MODIFIED_BY="[Empty name]" NAME="Bassi 2001" TYPE="JOURNAL_ARTICLE">
<AU>Bassi C, Falconi M, Salvia R, Mascetta G, Molinari E, Pederzoli P</AU>
<TI>Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients</TI>
<SO>Digestive Surgery</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>6</NO>
<PG>453-7</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:24:30 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Bassi-2005a" MODIFIED="2008-05-14 10:11:53 -0400" MODIFIED_BY="Cathy Bennett" NAME="Bassi 2005a" NOTES="&lt;p&gt;CORPORATE NAME: European Study Group for Pancreatic Cancer (ESPAC).&lt;/p&gt;" NOTES_MODIFIED="2008-05-14 10:11:53 -0400" NOTES_MODIFIED_BY="Cathy Bennett" TYPE="JOURNAL_ARTICLE">
<AU>Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H et al</AU>
<TI>Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial</TI>
<SO>Digestive Surgery</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>5</NO>
<PG>353-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bassi-2005b" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Bassi 2005b" NOTES="&lt;p&gt;CORPORATE NAME: International Study Group on Pancreatic Fistula Definition.&lt;/p&gt;" NOTES_MODIFIED="2011-03-08 09:18:20 -0500" NOTES_MODIFIED_BY="Karin L Dearness" TYPE="JOURNAL_ARTICLE">
<AU>Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al</AU>
<TI>Postoperative pancreatic fistula: an international study group (ISGPF) definition</TI>
<SO>Surgery</SO>
<YR>2005</YR>
<VL>138</VL>
<NO>1</NO>
<PG>8-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buchler-2003" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" NAME="Buchler 2003" TYPE="JOURNAL_ARTICLE">
<AU>Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K</AU>
<TI>Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy</TI>
<SO>Archives of Surgery</SO>
<YR>2003</YR>
<VL>138</VL>
<NO>12</NO>
<PG>1310-4</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:25:31 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Butturini-2006" MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness" NAME="Butturini 2006" TYPE="JOURNAL_ARTICLE">
<AU>Butturini G, Marcucci S, Molinari E, Mascetta G, Landoni L, Crippa S et al</AU>
<TI>Complications after pancreaticoduodenectomy: the problem of current definitions</TI>
<SO>Journal of Hepato-Biliary-Pancreatic Surgery</SO>
<YR>2006</YR>
<VL>13</VL>
<NO>3</NO>
<PG>207-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cameron-2015" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Cameron 2015" TYPE="JOURNAL_ARTICLE">
<AU>Cameron JL, He J</AU>
<TI>Two thousand consecutive pancreaticoduodenectomies</TI>
<SO>Journal of the American College of Surgeons</SO>
<YR>2015</YR>
<VL>220</VL>
<NO>4</NO>
<PG>530-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DerSimonian-1986" MODIFIED="2008-05-09 12:25:50 -0400" MODIFIED_BY="[Empty name]" NAME="DerSimonian 1986" TYPE="JOURNAL_ARTICLE">
<AU>DerSimonian R, Laird N</AU>
<TI>Meta-analysis in clinical trials</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1986</YR>
<VL>7</VL>
<NO>3</NO>
<PG>177-88</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:25:45 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Downs-1998" MODIFIED="2008-05-09 19:17:54 -0400" MODIFIED_BY="[Empty name]" NAME="Downs 1998" TYPE="JOURNAL_ARTICLE">
<AU>Downs SH, Black N</AU>
<TI>The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions</TI>
<SO>Journal of Epidemiology &amp; Community Health</SO>
<YR>1998</YR>
<VL>52</VL>
<NO>6</NO>
<PG>377-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997a" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Egger 1997a" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey SG, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629&#8211;34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997b" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Egger 1997b" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Smith GD</AU>
<TI>Meta-analysis. Potentials and promise</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7119</NO>
<PG>1371-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fitzsimmons-1998" MODIFIED="2008-05-09 12:27:14 -0400" MODIFIED_BY="[Empty name]" NAME="Fitzsimmons 1998" TYPE="JOURNAL_ARTICLE">
<AU>Fitzsimmons D, Johnson CD</AU>
<TI>Quality of life after treatment of pancreatic cancer</TI>
<SO>Langenbecks Archives of Surgery</SO>
<YR>1998</YR>
<VL>383</VL>
<NO>2</NO>
<PG>145-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gouma-1999" MODIFIED="2008-05-09 12:28:03 -0400" MODIFIED_BY="[Empty name]" NAME="Gouma 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gouma DJ, Nieveen van Dijkum EJ, van Geenen RC, van Gulik TM, Obertop H</AU>
<TI>Are there indications for palliative resection in pancreatic cancer?</TI>
<SO>World Journal of Surgery</SO>
<YR>1999</YR>
<VL>23</VL>
<NO>9</NO>
<PG>954-9</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:27:22 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Gouma-2000" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Gouma 2000" TYPE="JOURNAL_ARTICLE">
<AU>Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR et al</AU>
<TI>Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume</TI>
<SO>Annals of Surgery</SO>
<YR>2000</YR>
<VL>232</VL>
<NO>6</NO>
<PG>786-95</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:28:35 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-GRADE-2008" MODIFIED="2011-04-11 09:41:57 -0400" MODIFIED_BY="[Empty name]" NAME="GRADE 2008" TYPE="COMPUTER_PROGRAM">
<AU>Brozek J, Oxman A, Schünemann H</AU>
<TI>GRADEpro</TI>
<YR>2008</YR>
<EN>3.2 for Windows</EN>
<PB>GRADE Working Group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hackert-2013" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Hackert 2013" TYPE="JOURNAL_ARTICLE">
<AU>Hackert T, Bruckner T, Dörr-Harim C, Diener MK, Knebel P, Hartwig W et al</AU>
<TI>Pylorus resection or pylorus preservation in partial pancreatico-duodenectomy (PROPP study): study protocol for a randomized controlled trial</TI>
<SO>Trials</SO>
<YR>2013</YR>
<VL>14</VL>
<PG>44</PG>
<IDENTIFIERS MODIFIED="2015-12-03 11:32:46 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-12-03 11:32:46 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1745-6215-14-44"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2005" MODIFIED="2016-02-05 10:48:43 -0500" MODIFIED_BY="[Empty name]" NAME="Higgins 2005" TYPE="OTHER">
<TI>Appendix 5b. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. In: Higgins JPT, Green S, editors. Cochrane Handbook of Systematic Reviews of Interventions 4.2.5</TI>
<SO>The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley and Sons, Ltd</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al</AU>
<TI>The Cochrane Collaboration's tool for assessing risk of bias in randomised trials</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>343</VL>
<PG>d5928</PG>
<IDENTIFIERS MODIFIED="2015-12-01 13:41:28 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-12-01 13:41:28 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmj.d5928"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hozo-2005" MODIFIED="2016-02-05 02:58:49 -0500" MODIFIED_BY="[Empty name]" NAME="Hozo 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hozo SP, Djulbegovic B, Hozo I</AU>
<TI>Estimating the mean and variance from the median, range, and the size of a sample</TI>
<SO>BMC Medical Research Methodology</SO>
<YR>2005</YR>
<VL>5</VL>
<PG>13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Iqbal-2008" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Iqbal 2008" TYPE="JOURNAL_ARTICLE">
<AU>Iqbal N, Lovegrove RE, Tilney HS, Abraham AT, Bhattacharya S, Tekkis PP et al</AU>
<TI>A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy: a meta-analysis of 2822 patients</TI>
<SO>European Journal of Surgical Oncology</SO>
<YR>2008</YR>
<VL>34</VL>
<NO>11</NO>
<PG>1237-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Karanicolas-2007" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Karanicolas 2007" TYPE="JOURNAL_ARTICLE">
<AU>Karanicolas PJ, Davies E, Kunz R, Briel M, Koka HP, Payne DM</AU>
<TI>The pylorus: take it or leave it? Systematic review and meta-analysis of pylorus-preserving versus standard whipple pancreaticoduodenectomy for pancreatic or periampullary cancer</TI>
<SO>Annals of Surgical Oncology</SO>
<YR>2007</YR>
<VL>14</VL>
<NO>6</NO>
<PG>1825-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kausch-1912" MODIFIED="2008-05-09 12:34:45 -0400" MODIFIED_BY="[Empty name]" NAME="Kausch 1912" TYPE="JOURNAL_ARTICLE">
<AU>Kausch W</AU>
<TI>Carcinoma of the duodenal papilla and its radical excision</TI>
<TO>Das Carcinom der Papilla duodeni und seine radikale Entfernung</TO>
<SO>Beitrage zur Klinischen Chirurgie</SO>
<YR>1912</YR>
<VL>78</VL>
<PG>439-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kawai-2011" MODIFIED="2016-02-05 03:01:35 -0500" MODIFIED_BY="[Empty name]" NAME="Kawai 2011" TYPE="JOURNAL_ARTICLE">
<AU>Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Uchiyama K et al</AU>
<TI>Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy</TI>
<SO>Annals of Surgery</SO>
<YR>2011</YR>
<VL>253</VL>
<NO>3</NO>
<PG>495-501</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kohler-2015" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Kohler 2015" TYPE="JOURNAL_ARTICLE">
<AU>Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA et al</AU>
<TI>Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>2015</YR>
<VL>107</VL>
<NO>6</NO>
<PG>djv048</PG>
<IDENTIFIERS MODIFIED="2015-12-02 05:00:12 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-12-02 05:00:12 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/jnci/djv048"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Koslowsky-2001" MODIFIED="2008-05-14 12:00:18 -0400" MODIFIED_BY="Cathy Bennett" NAME="Koslowsky 2001" TYPE="JOURNAL_ARTICLE">
<AU>Koslowsky TC, Wilke J, Voiss W, Michaelis S, Balta D, Siedek M</AU>
<TI>Surgical palliation of pancreatic carcinoma. Results of a 7 year period</TI>
<SO>Chirurg</SO>
<YR>2001</YR>
<VL>72</VL>
<NO>6</NO>
<PG>704-9</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:35:24 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Kunz-1998" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Kunz 1998" TYPE="JOURNAL_ARTICLE">
<AU>Kunz R, Oxman AD</AU>
<TI>The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<PG>1185-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lillemoe-1996" MODIFIED="2008-05-14 12:00:34 -0400" MODIFIED_BY="Cathy Bennett" NAME="Lillemoe 1996" TYPE="JOURNAL_ARTICLE">
<AU>Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK et al</AU>
<TI>Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?</TI>
<SO>Annals of Surgery</SO>
<YR>1996</YR>
<VL>223</VL>
<NO>6</NO>
<PG>718-25</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:35:47 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Lillemoe-2000" MODIFIED="2011-03-08 08:12:26 -0500" MODIFIED_BY="[Empty name]" NAME="Lillemoe 2000" TYPE="JOURNAL_ARTICLE">
<AU>Lillemoe KD, Yeo CJ, Cameron JL</AU>
<TI>Pancreatic cancer: state-of-the-art care</TI>
<SO>CA: A Cancer Journal for Clinicians</SO>
<YR>2000</YR>
<VL>50</VL>
<NO>4</NO>
<PG>241-68</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:36:18 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2016-02-05 03:07:04 -0500" MODIFIED_BY="[Empty name]" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>The Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:36:45 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Mosca-1997" MODIFIED="2008-05-09 12:37:01 -0400" MODIFIED_BY="[Empty name]" NAME="Mosca 1997" TYPE="JOURNAL_ARTICLE">
<AU>Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F et al</AU>
<TI>Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy</TI>
<SO>Surgery</SO>
<YR>1997</YR>
<VL>122</VL>
<NO>3</NO>
<PG>553-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mulrow-1994" MODIFIED="2008-05-09 12:37:31 -0400" MODIFIED_BY="[Empty name]" NAME="Mulrow 1994" TYPE="JOURNAL_ARTICLE">
<AU>Mulrow CD</AU>
<TI>Rationale for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<NO>6954</NO>
<PG>597-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Neoptolemos-2001" NAME="Neoptolemos 2001" NOTES="&lt;p&gt;CORPORATE NAME: European Study Group for Pancreatic Cancer.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P et al</AU>
<TI>Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial</TI>
<SO>Annals of Surgery</SO>
<YR>2001</YR>
<VL>234</VL>
<NO>6</NO>
<PG>758-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oettle-2013" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Oettle 2013" TYPE="JOURNAL_ARTICLE">
<AU>Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K et al</AU>
<TI>Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial</TI>
<SO>JAMA</SO>
<YR>2013</YR>
<VL>310</VL>
<NO>14</NO>
<PG>1473-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parmar-1998" NAME="Parmar 1998" TYPE="JOURNAL_ARTICLE">
<AU>Parmar MK, Torri V, Stewart L</AU>
<TI>Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints</TI>
<SO>Statistics in Medicine</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>24</NO>
<PG>2815-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2016-02-05 10:33:16 -0500" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richter-2003" MODIFIED="2008-05-09 12:38:01 -0400" MODIFIED_BY="[Empty name]" NAME="Richter 2003" TYPE="JOURNAL_ARTICLE">
<AU>Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M</AU>
<TI>Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience</TI>
<SO>World Journal of Surgery</SO>
<YR>2003</YR>
<VL>27</VL>
<NO>3</NO>
<PG>324-9</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:37:57 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Roder-1992" MODIFIED="2008-05-09 12:38:12 -0400" MODIFIED_BY="[Empty name]" NAME="Roder 1992" TYPE="JOURNAL_ARTICLE">
<AU>Roder JD, Stein HJ, Huttl W, Siewert JR</AU>
<TI>Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas</TI>
<SO>British Journal of Surgery</SO>
<YR>1992</YR>
<VL>79</VL>
<NO>2</NO>
<PG>152-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Siegel-2015" MODIFIED="2016-02-05 03:11:53 -0500" MODIFIED_BY="[Empty name]" NAME="Siegel 2015" TYPE="JOURNAL_ARTICLE">
<AU>Siegel RL, Miller KD, Jemal A</AU>
<TI>Cancer statistics, 2015</TI>
<SO>CA: A Cancer Journal for Clinicians</SO>
<YR>2015</YR>
<VL>65</VL>
<NO>1</NO>
<PG>5-29</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tierney-2007" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Tierney 2007" TYPE="JOURNAL_ARTICLE">
<AU>Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR</AU>
<TI>Practical methods for incorporating summary time-to-event data into meta-analysis</TI>
<SO>Trials</SO>
<YR>2007</YR>
<VL>8</VL>
<PG>16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Traverso-1980" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" NAME="Traverso 1980" TYPE="JOURNAL_ARTICLE">
<AU>Traverso LW, Longmire WP Jr</AU>
<TI>Preservation of the pylorus in pancreaticoduodenectomy: a follow-up evaluation</TI>
<SO>Annals of Surgery</SO>
<YR>1980</YR>
<VL>192</VL>
<NO>3</NO>
<PG>306-10</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:39:33 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Trede-1990" MODIFIED="2008-05-09 12:40:01 -0400" MODIFIED_BY="[Empty name]" NAME="Trede 1990" TYPE="JOURNAL_ARTICLE">
<AU>Trede M, Schwall G, Saeger HD</AU>
<TI>Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality</TI>
<SO>Annals of Surgery</SO>
<YR>1990</YR>
<VL>211</VL>
<NO>4</NO>
<PG>447-58</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:39:57 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Trede-1993" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" NAME="Trede 1993" TYPE="BOOK">
<AU>Trede M, Carter DC</AU>
<SO>Surgery of the Pancreas</SO>
<YR>1993</YR>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS MODIFIED="2008-05-09 12:40:19 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Watson-1944" MODIFIED="2008-05-09 12:40:26 -0400" MODIFIED_BY="[Empty name]" NAME="Watson 1944" TYPE="JOURNAL_ARTICLE">
<AU>Watson K</AU>
<TI>Carcinoma of the ampulla of Vater. Successful radical resection</TI>
<SO>British Journal of Surgery</SO>
<YR>1944</YR>
<VL>31</VL>
<PG>368-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wente-2007a" MODIFIED="2016-02-05 03:15:27 -0500" MODIFIED_BY="[Empty name]" NAME="Wente 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al</AU>
<TI>Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition</TI>
<SO>Surgery</SO>
<YR>2007</YR>
<VL>142</VL>
<NO>1</NO>
<PG>20-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wente-2007b" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NAME="Wente 2007b" TYPE="JOURNAL_ARTICLE">
<AU>Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al</AU>
<TI>Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)</TI>
<SO>Surgery</SO>
<YR>2007</YR>
<VL>142</VL>
<NO>5</NO>
<PG>761-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whipple-1935" MODIFIED="2008-05-14 12:00:46 -0400" MODIFIED_BY="Cathy Bennett" NAME="Whipple 1935" TYPE="JOURNAL_ARTICLE">
<AU>Whipple AO, Parsons WB, Mullins CR</AU>
<TI>Treatment of carcinoma of the ampulla of Vater</TI>
<SO>Annals of Surgery</SO>
<YR>1935</YR>
<VL>102</VL>
<PG>763-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williamson-1993" MODIFIED="2008-05-09 12:41:26 -0400" MODIFIED_BY="[Empty name]" NAME="Williamson 1993" TYPE="JOURNAL_ARTICLE">
<AU>Williamson RC, Bliouras N, Cooper MJ, Davies ER</AU>
<TI>Gastric emptying and enterogastric reflux after conservative and conventional pancreatoduodenectomy</TI>
<SO>Surgery</SO>
<YR>1993</YR>
<VL>114</VL>
<NO>1</NO>
<PG>82-6</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:41:23 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Yeo-1997" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Yeo 1997" TYPE="JOURNAL_ARTICLE">
<AU>Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al</AU>
<TI>Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes</TI>
<SO>Annals of Surgery</SO>
<YR>1997</YR>
<VL>226</VL>
<NO>3</NO>
<PG>248-57</PG>
<IDENTIFIERS MODIFIED="2008-05-09 12:42:32 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-02-05 03:22:34 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Diener-2007" MODIFIED="2008-05-09 12:42:53 -0400" MODIFIED_BY="[Empty name]" NAME="Diener 2007" TYPE="JOURNAL_ARTICLE">
<AU>Diener MK, Knaebel HP, Heukaufer C, Antes G, Buchler MW, Seiler CM</AU>
<TI>A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma</TI>
<SO>Annals of Surgery</SO>
<YR>2007</YR>
<VL>245</VL>
<NO>2</NO>
<PG>187-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Diener-2008" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" NAME="Diener 2008" TYPE="COCHRANE_REVIEW">
<AU>Diener MK, Heukaeufer C, Schwarzer G, Seiler CM, Antes G, Knaebel H-P et al</AU>
<TI>Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2011-02-22 14:37:48 -0500" MODIFIED_BY="Karin L Dearness">
<IDENTIFIER MODIFIED="2011-02-22 14:37:48 -0500" MODIFIED_BY="Karin L Dearness" TYPE="DOI" VALUE="10.1002/14651858.CD006053.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Diener-2011" MODIFIED="2016-02-05 03:21:50 -0500" MODIFIED_BY="[Empty name]" NAME="Diener 2011" TYPE="COCHRANE_REVIEW">
<AU>Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP et al</AU>
<TI>Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>5</NO>
<IDENTIFIERS MODIFIED="2015-12-01 13:01:00 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-12-01 13:01:00 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006053.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Diener-2014" MODIFIED="2016-02-05 03:22:34 -0500" MODIFIED_BY="[Empty name]" NAME="Diener 2014" TYPE="COCHRANE_REVIEW">
<AU>Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Hüttner FJ, Antes G et al</AU>
<TI>Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2015-12-01 13:02:10 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-12-01 13:02:10 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006053.pub5"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bloechle-1999">
<CHAR_METHODS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: unknown<BR/>Number randomly assigned: 44 (PPW = 23, CW = 21)<BR/>Exclusion after randomisation (total and per group): none<BR/>Losses to follow-up: yes<BR/>Method of allocation concealment: unknown<BR/>Intention-to-treat analysis: no<BR/>Description of sample size calculation: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 69 (47 to 76) (median and range in the PPW group); 67 (43 to 78) (median and range in the CW group)<BR/>Sex ratio (m/f): 1.6 (PPW), 1.5 (CW)<BR/>Inclusion criteria: people with periampullary carcinoma (cT1-4, cN0-1, cM0)<BR/>Exclusion criteria: none<BR/>Equivalence of baseline characteristics: age and stage distribution similar for both groups<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>PPW and CW (no operation details available)<BR/>Erythromycin application unknown<BR/>Somatostatin application unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Description of outcome parameters: insufficient<BR/>Operation time (minutes): PPW: 239 ± 79; CW: 285 ± 91<BR/>Postoperative mortality: PPW: 0%; CW: 0%<BR/>DGE: PPW: 8 (34%); CW: 2 (9%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Country: Germany<BR/>Time of enrolment: unknown<BR/>Duration of follow-up: median 18 months (range 12 to 30)<BR/>The trial investigator did not define the term &#8216;periampullary cancer&#8217;; we assume that it includes people with pancreatic head cancer</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lin-1999">
<CHAR_METHODS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: unknown<BR/>Number randomly assigned: 33 (PPW = 14, CW = 19)<BR/>Exclusion after randomisation (total and per group): 3 (PPW = 3, CW = 0)<BR/>Losses to follow-up: yes<BR/>Method of allocation concealment: unknown<BR/>Intention-to-treat analysis: no<BR/>Description of sample size calculation: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 64.5 (48 to 77) (mean and range in the PPW group); 66.7 (46 to 84) (mean and range in the CW group)<BR/>Sex: ratio (m/f): 2.5 (PPW), 2.2 (CW)<BR/>Inclusion criteria: people with pancreatic head carcinoma<BR/>Exclusion criteria: none<BR/>Equivalence of baseline characteristics: Participants were equivalent in terms of age and sex distribution; the CW group included more participants with stage III cancer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>PPW and CW (no operation details available)<BR/>No somatostatin used<BR/>Erythromycin application unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Operation time (minutes): PPW: 221 ± 35; CW: 271 ± 65<BR/>Intraoperative blood loss (ml): PPW: 446 ± 342; CW: 1212 ± 194<BR/>Blood replacement (units): PPW: 1.0 ± 1.4; CW: 1.6 ± 2.6<BR/>Postoperative mortality: PPW: 1 (7.1%); CW: 0 (0%)<BR/>DGE: PPW: 6 (42.8%); CW: 0 (0%)<BR/>Bleeding: PPW: 0 (0%); CW: 1 (5.2%)<BR/>Fistula: PPW: 1 (7.1%); CW: 1 (5.2%)<BR/>Bile leak: PPW: 0 (0%); CW: 0 (0%)<BR/>Wound infection: PPW: 1 (7.1%); CW: 1 (5.2%)<BR/>Intra-abdominal abscess: PPW: 0 (0%); CW: 1 (5.2%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Taiwan<BR/>Time of enrolment: 156 weeks<BR/>Duration of follow-up: unknown</P>
<P>All operations performed by the same surgeon</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paquet-1998">
<CHAR_METHODS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: sealed envelopes (information from study author)<BR/>Number randomly assigned: 40 (PPW = 17, CW = 23)<BR/>Exclusion after randomisation (total and per group): unknown<BR/>Losses to follow-up: unknown<BR/>Method of allocation concealment: unknown<BR/>Intention-to-treat analysis: no<BR/>Description of sample size calculation: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: unknown<BR/>Sex: unknown<BR/>Inclusion criteria: people with pancreatic adenocarcinoma or periampullary cancer and an R0 resection<BR/>Exclusion criteria: none<BR/>Equivalence of baseline characteristics: unknown</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-08 14:17:09 -0400" MODIFIED_BY="[Empty name]">
<P>Anastomoses: retrocolic end-to-end pancreaticojejunostomy with a drain in the pancreatic duct, end-to-end hepaticojejunostomy, end-to-end duodenojejunostomy<BR/>Erythromycin application unknown<BR/>Somatostatin application unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Description of outcome parameters: insufficient<BR/>Postoperative mortality: PPW: 0 (0%); CW: 1 (4%)<BR/>DGE: PPW: 6 (35%); CW: 1 (4%)<BR/>Fistula: PPW: 1 (6%); CW: 2 (9%)<BR/>Radicality (R0): PPW: 17 (100%); CW: 23 (100%) (condition for inclusion)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Germany<BR/>Time of enrolment: 521 weeks<BR/>Duration of follow-up: minimum = 24 months, maximum = 144 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seiler-2005">
<CHAR_METHODS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: sealed envelopes<BR/>Number randomly assigned: 130 (PPW = 64, CW = 66)<BR/>Exclusion after randomisation (total): 84 (group distribution unknown)<BR/>Losses to follow-up: unknown<BR/>Method of allocation concealment: unknown<BR/>Intention-to-treat analysis: no<BR/>Description of sample size calculation: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 64.8 (26 to 83) (median and range in the PPW group); 65 (33 to 86) (median and range in the CW group)<BR/>Sex: ratio (m/f): 1.29 (PPW), 1 (CW)<BR/>Inclusion criteria: all people suitable for surgery with suspected pancreatic or periampullary cancer considered resectable on the basis of computed tomography or magnetic resonance imaging, with no history of previous gastric resection<BR/>Exclusion criteria: direct tumour invasion of the proximal duodenum, pylorus, or stomach; peripyloric lymph node metastases confirmed by intraoperative frozen-section examination; distant metastases or locally unresectable tumours due to major retroperitoneal infiltration; emergency resections; necessity for total pancreatectomy to achieve clear resection margins<BR/>Equivalence of baseline characteristics: Groups were similar regarding age, sex, and stage distribution</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Reconstruction performed by means of an interrupted 2-layer end-to-side pancreaticojejunostomy, an end-to side hepaticojejunostomy 10 to 15 cm distal to the pancreatic anastomosis, and an end-to-side gastrojejunostomy/duodenojejunostomy approximately 40 cm distal to the biliodigestive anastomosis, followed by a Braun jejunojejunostomy<BR/>Somatostatin application: 100 to 200 µg three times a day for a total of seven days<BR/>Erythromycin application: none<BR/>Perioperative treatment: antibiotic prophylaxis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Operation time (minutes): PPW: 382 (240 to 645); CW: 449 (240 to 780)<BR/>Intraoperative blood loss (ml): PPW: 1198 (400 to 4000); CW: 1500 (400 to 6000)<BR/>Blood replacement (units): PPW: 0.9 (0 to 6); CW: 1.9 (0 to 10)<BR/>Hospital stay (days): PPW: 19.7 (10 to 61); CW: 20.8 (8 to 67)<BR/>Postoperative mortality: PPW: 1 (2%); CW: 2 (3%)<BR/>DGE: PPW: 20 (31%); CW: 30 (45%)<BR/>Bleeding: PPW: 2 (3%); CW: 4 (6%)<BR/>Fistula: PPW: 2 (3%); CW: 1 (2%)<BR/>Bile leak: PPW: 0 (0%); CW: 1 (1.5%)<BR/>Infection (wound or abscess): PPW: 4 (6%); CW: 4 (6%)<BR/>Positive LNs: PPW: 33 (62%); CW: 41 (72%)<BR/>Radicality (R0): PPW: 48 (91%); CW: 45 (79%)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Germany<BR/>Time of enrolment: 274 weeks<BR/>Duration of follow-up: median = 63.1 months, minimum = 4 months, maximum = 93 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Srinarmwong-2008">
<CHAR_METHODS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: computer-generated random lists<BR/>Number randomly assigned: 27 (PPW = 14, CW = 13)<BR/>Exclusion after randomisation (total and per group): none<BR/>Losses to follow-up: unknown<BR/>Method of allocation concealment: sealed, opaque envelopes<BR/>Intention-to-treat analysis: unknown<BR/>Description of sample size calculation: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 61.8 (51 to 74) (median and range in the PPW group); 63.3 (52 to 72) (median and range in the CW group)<BR/>Sex: ratio (m/f): 2.5 (PPW), 1.6 (CW)<BR/>Inclusion criteria: all people with suspected pancreatic or periampullary cancer evaluated to have resectable disease<BR/>Exclusion criteria: previous gastric resection; distant metastases; unresectable tumours; tumour invasion of pylorus or stomach; refusal to participate<BR/>Equivalence of baseline characteristics: Groups were similar regarding age, sex, distribution of pancreatic and periampullary cancer, positive lymph nodes, and mesenteric vessel involvement</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Resection line: 2 cm distal to the pylorus (PPW group); 20% to 40% of the stomach resected (CW group)</P>
<P>Reconstruction performed by means of an end-to-side invaginated pancreaticojejunostomy, an end-to side hepaticojejunostomy, and an end-to-side duodenojejunostomy in the PPW group or a side-to-side gastrojejunostomy in the CW group<BR/>Somatostatin application: 100 µg three times a day for a total of seven days<BR/>Erythromycin application: unknown<BR/>Perioperative treatment: antibiotic prophylaxis (cefazolin + metronidazole); H2-antagonists postoperatively</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Operation time (minutes): PPW: 303 (245 to 367); CW: 316 (287 to 360)<BR/>Intraoperative blood loss (ml): PPW: 1850 (1300 to 2400); CW: 1946 (1200 to 2600)</P>
<P>Hospital stay (days): PPW: 22 (12 to 28); CW: 20 (11 to 24)<BR/>Postoperative mortality: PPW: 4 (28.6%); CW: 2 (15.4%)<BR/>DGE: PPW: 9 (64.3%); CW: 2 (15.4%)<BR/>Bleeding: PPW: 1 (7.1%); CW: 1 (7.7%)<BR/>Fistula: PPW: 5 (35.7%); CW: 4 (30.8%)</P>
<P>Bile leak: PPW: 2 (14.3%); CW: 0 (0%)<BR/>Positive LNs: PPW: 10 (71.4%); 11 (84.6%)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<P>Country: Thailand<BR/>Time of enrolment: 260 weeks<BR/>Duration of follow-up: minimum = 24 months, maximum = 60 months; follow-up every 3 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taher-2015">
<CHAR_METHODS MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: unknown<BR/>Number randomly assigned: 20 (PPW = 12, CW = 8)<BR/>Exclusion after randomisation (total and per group): none<BR/>Losses to follow-up: unknown<BR/>Method of allocation concealment: unknown<BR/>Intention-to-treat analysis: unknown<BR/>Description of sample size calculation: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 50.3 ± 10.6 (mean and SD in the PPW group); 44 ± 10.9 (mean and SD in the CW group)<BR/>Sex: ratio (m/f): 5.66 (total)<BR/>Inclusion criteria: all people suitable for surgery with carcinoma of the head of the pancreas or the periampullary region<BR/>Exclusion criteria: people with distant metastases<BR/>Equivalence of baseline characteristics: only scarce data, age not significantly different; all participants in the CW group had periampullary cancer, whereas in the PPW group 8 of 12 participants had periampullary cancer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-04 22:34:28 -0500" MODIFIED_BY="[Empty name]">
<P>PPW and CW (no operation details available)</P>
<P>Erythromycin application unknown<BR/>Somatostatin application unknown</P>
<P>Perioperative treatment details unknown<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Operation time (minutes): PPW: 308 ± 46; CW: 356 ± 47<BR/>Blood replacement (units): PPW: 2.67 ± 0.65; CW: 2.88 ± 0.64<BR/>Hospital stay (days): PPW: 24.9 ± 6.7; CW: 28.1 ± 9.1<BR/>Postoperative mortality: PPW: 0 (0%); CW: 1 (12.5%)<BR/>DGE: PPW: 4 (33%); CW: 1 (12.5%)<BR/>Bleeding: PPW: 1 (8.3%); CW: 1 (12.5%)<BR/>Fistula: PPW: 1 (8.3%); CW: 0 (0%)<BR/>Bile leak: PPW: 1 (8.3%); CW: 3 (37.5%)</P>
<P>Re-laparotomy: PPW: 1 (8.3%); CW: 1 (12.5%)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<P>Country: Bangladesh<BR/>Time of enrolment: 104 weeks<BR/>Duration of follow-up: unknown</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tran-2004">
<CHAR_METHODS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: sealed envelopes<BR/>Number randomly assigned: 170 (PPW = 87, CW = 83)<BR/>Exclusion after randomisation (total and per group): 36 (PPW = 17, CW = 19)<BR/>Losses to follow-up: unknown<BR/>Method of allocation concealment: sealed, opaque envelopes<BR/>Intention-to-treat analysis: yes<BR/>Description of sample size calculation: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 64 (43 to 78) (median and range in the PPW group); 62 (27 to 78) (median and range in the CW group)<BR/>Sex: ratio (m/f): 2.32 (PPW), 1.35 (CW)<BR/>Inclusion criteria: inclusion of consecutive patients with suspected pancreatic or periampullary cancer that was assumed to be resectable according to preoperative diagnostic imaging<BR/>Exclusion criteria: previous gastric resection, distant metastasis or local unresectable tumours, direct invasion of the pylorus or stomach, positive peripyloric lymph nodes<BR/>Equivalence of baseline characteristics: groups similar regarding age, sex, and stage distribution</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>End-to-side invaginated pancreaticojejunostomy, end-to-side hepaticojejunostomy, side-to-side gastroenterostomy, or end-to-side pylorus-jejunostomy<BR/>Somatostatin application: 100 µg preoperatively + three times a day for a total of seven days<BR/>Erythromycin application: none<BR/>Perioperative treatment: antibiotic prophylaxis, H2-antagonists, drain in operation area</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Operation time (minutes): PPW: 300 (130 to 600); CW: 300 (160 to 480)<BR/>Intraoperative blood loss (ml): PPW: 2000 (400 to 21,000); CW: 2000 (300 to 9500)<BR/>Blood replacement (units): PPW: 2; CW: 2<BR/>Hospital stay (days): PPW: 18 (4 to 175); CW: 20 (11 to 138)<BR/>Postoperative mortality: PPW: 3 (3%); CW: 6 (7%)<BR/>DGE: PPW: 19/85 (22%); CW: 18/80 (23%)<BR/>Bleeding: PPW: 6 (7%); CW: 6 (7%)<BR/>Fistula: PPW: 11 (13%); CW: 12 (14%)<BR/>Bile leak: PPW: 2 (2%); CW: 0 (0%)<BR/>Intra-abdominal abscess: PPW: 9 (10%); CW: 8 (10%)<BR/>Re-laparotomy: PPW: 13 (15%); CW: 16 (19%)<BR/>Positive LNs: PPW: 37/72 (51.4%); 38/69 (55%)<BR/>Radicality (R0): PPW: 53/72 (73.6%); CW: 57/69 (82.6%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<P>Country: Netherlands<BR/>Time of enrolment: 465 weeks<BR/>Duration of follow-up: median = 18.5 months, minimum = 1 month, maximum = 115 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wenger-1999">
<CHAR_METHODS MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: unknown<BR/>Number randomly assigned: 48 (PPW = 24, CW = 24)<BR/>Exclusion after randomisation (total and per group): none<BR/>Method of allocation concealment: unknown<BR/>Intention-to-treat analysis: no<BR/>Description of sample size calculation: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Age, years: 61.2 ± 7.2 (mean and SD in the PPW group); 61.6 ± 8.9 (mean and SD in the CW group)<BR/>Sex: ratio (m/f): 1 (PPW), 1 (CW)<BR/>Inclusion criteria: all people with a preoperative diagnosis of a ductal carcinoma of the pancreatic head or a periampullary carcinoma, an R0 resection, and postoperative affirmation of the diagnosis<BR/>Exclusion criteria: tumour infiltration of the stomach, the superior part of the duodenum, or the pylorus; age &gt; 75; peritoneal carcinosis; reduced general condition; heart insufficiency; renal insufficiency; hepatic insufficiency; pulmonary insufficiency<BR/>Equivalence of baseline characteristics: groups similar regarding age, sex, and stage distribution</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-05-08 14:44:25 -0400" MODIFIED_BY="[Empty name]">
<P>PPW and CW (no description of procedures)<BR/>Somatostatin application: unknown<BR/>Erythromycin application: unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>Operation time (minutes): PPW: 206 ± 48; CW: 306 ± 54<BR/>Blood replacement (units): PPW: 5.5 ± 3.1; CW: 6.3 ± 5.2<BR/>Hospital stay (days): PPW: 19.1 ± 11.3; CW: 20.9 ± 13.8<BR/>Wound infection: PPW: 3 (12.5%); CW: 4 (16.6%)<BR/>Positive LNs: PPW: 12 (50%); CW: 13 (54%)<BR/>Radicality (R0): PPW: 24 (100%); CW: 24 (100%)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Country: Germany<BR/>Time period for enrolment: 208 weeks<BR/>Follow-up: assessed at 2, 6, 12, 24, 36, 48, and 60 weeks; median and range not available</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CW: classic Whipple<BR/>DGE: delayed gastric emptying<BR/>LNs: lymph nodes<BR/>PPW: pylorus-preserving Whipple<BR/>SD: standard deviation</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Bakkevold-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>Non-randomised study design; no comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Bassi-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bell-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">
<P>Narrative review of 1 included RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Brennan-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Buchler-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Chou-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Farnell-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Friess-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Johnstone-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Nguyen-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Pedrazzoli-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seiler-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Additional publication on the same trial (<LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK>). No further information</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" STUDY_ID="STD-Shan-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness">
<P>No comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 08:03:17 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Berge-Henegouwen">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 08:03:17 -0500" MODIFIED_BY="[Empty name]">
<P>Non-randomised study design; insufficient quantitative outcome parameters</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-08 08:03:19 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wagner-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-08 08:03:19 -0500" MODIFIED_BY="[Empty name]">
<P>Non-randomised study design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yeo-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<P>Study not randomised for the comparison of PPW versus CW</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CW: classic Whipple<BR/>PPW: pylorus-preserving Whipple<BR/>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-11 09:29:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: computer-generated random list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: "total 20 patients [...] were enrolled [...] and randomly allocated"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-04-11 09:29:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: "Sealed envelopes" were used (information obtained from the study author upon request)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: envelopes used for randomisation but unclear whether envelopes were opaque</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: sealed, opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Quote: "An equal number of blind envelopes with protocols for the SW and the PPPD resection was prepared. The envelopes were used sequentially as patients were enrolled in the study. Therefore, there was strict randomization in both arms. Randomization was carried out in the operation room: a sealed envelope was opened only after it was ascertained that both operation techniques were feasible in the patient concerned"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-11 13:10:12 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-11 13:12:36 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-11 13:12:52 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-11 13:13:04 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-11 13:13:20 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-04-11 13:13:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-11 13:10:19 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-11 13:12:42 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-11 13:12:59 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-11 13:13:06 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-11 13:13:22 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-11 13:13:33 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: Postrandomisation dropouts could have influenced effect estimates</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: Postrandomisation dropouts could have influenced effect estimates</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: no postrandomisation dropouts reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: no postrandomisation dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: no postrandomisation dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: no postrandomisation dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Comment: Reasons for exclusion from long-term survival analysis are given (e.g. non-malignant disease)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: no postrandomisation dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: no study protocol available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: no study protocol available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: no study protocol available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Tran-2004">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="UNKNOWN" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:19 -0500" MODIFIED_BY="Karin L Dearness" RESULT="NO" STUDY_ID="STD-Bloechle-1999">
<DESCRIPTION>
<P>Comment: sample size calculation not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="NO" STUDY_ID="STD-Lin-1999">
<DESCRIPTION>
<P>Comment: sample size calculation not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="NO" STUDY_ID="STD-Paquet-1998">
<DESCRIPTION>
<P>Comment: sample size calculation not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Seiler-2005">
<DESCRIPTION>
<P>&#8212;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Srinarmwong-2008">
<DESCRIPTION>
<P>Comment: sample size calculation not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Taher-2015">
<DESCRIPTION>
<P>Comment: sample size calculation not reported; ambiguities in report of the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-05-07 20:54:32 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tran-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 09:18:20 -0500" MODIFIED_BY="Karin L Dearness" RESULT="NO" STUDY_ID="STD-Wenger-1999">
<DESCRIPTION>
<P>Comment: sample size calculation not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">Postoperative mortality and DGE after surgical treatment for periampullary or pancreatic carcinoma</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TD COLSPAN="7">
<P>
<B>Postoperative </B>
<B>mortality and DGE after surgical treatment for periampullary or pancreatic carcinoma</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> people with surgical treatment for periampullary or pancreatic carcinoma<BR/>
<B>Settings: </B>surgical departments in Asia and Europe<BR/>
<B>Intervention:</B> PPW</P>
<P>
<B>Comparison:</B> CW<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>CW</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>PPW</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Postoperative mortality</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>60 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>39 per 1000</B>
<BR/>(16 to 89)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>OR 0.64 </B>
<BR/>(0.26 to 1.54)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>464<BR/>(7 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>a</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Pancreatic fistula</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>93 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>88 per 1000</B>
</P>
<P>(48 to 158)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>OR 0.95</B>
</P>
<P>(0.49 to 1.84)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>468</P>
<P>(7 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;</P>
<P>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>DGE</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>235 per 1000</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>482 per 1000</B>
</P>
<P>(244 to 728)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>OR 3.03</B>
</P>
<P>(1.05 to 8.70)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>459</P>
<P>(7 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> was the mean risk in the control group across studies. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>CW:</B> classic Whipple; <B>DGE:</B> delayed gastric emptying; <B>OR:</B> odds ratio; <B>PPW:</B> pylorus-preserving Whipple</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Confidence intervals are wide due to small number of events. No sample size calculation was reported for trials except for <LINK REF="STD-Seiler-2005" TYPE="STUDY">Seiler 2005</LINK> and <LINK REF="STD-Tran-2004" TYPE="STUDY">Tran 2004</LINK>.<BR/>
<SUP>b</SUP>Strong heterogeneity due to differing outcome definitions and clinical heterogeneity between trials.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2014-10-27 10:30:23 -0400" MODIFIED_BY="[Empty name]">Survival after surgical treatment for periampullary or pancreatic carcinoma</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TD COLSPAN="7">
<P>
<B>Survival after surgical treatment for periampullary or pancreatic carcinoma</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> people with surgical treatment for periampullary or pancreatic carcinoma<BR/>
<B>Settings: </B>surgical departments in Asia and Europe<BR/>
<B>Intervention:</B> PPW</P>
<P>
<B>Comparison:</B> CW<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="BOTTOM">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>CW</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>PPW</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Overall survival</B>
<BR/>Follow-up: 18 to 144 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>
<B>Medium-risk population</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>HR 0.84 </B>
<BR/>(0.61 to 1.16)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>284<BR/>(3 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>CW:</B> classic Whipple; <B>HR:</B> hazard ratio; <B>PPW:</B> pylorus-preserving Whipple</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Inadequate information about sequence generation and allocation concealment. No intention-to-treat analysis.<BR/>
<SUP>b</SUP>Very wide confidence intervals, unknown number of losses to follow-up, low total number of events, no sample size calculations reported.</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2016-02-05 11:02:27 -0500" MODIFIED_BY="[Empty name]" NO="3" READONLY="YES">
<TITLE MODIFIED="2016-02-04 23:39:45 -0500" MODIFIED_BY="[Empty name]">Operating time, intraoperative blood loss, and red blood cell transfusion in surgical treatment for periampullary or pancreatic carcinoma</TITLE>
<TABLE COLS="6" ROWS="9">
<TR>
<TD COLSPAN="6">
<P>
<B>Operating time, intraoperative blood loss, and red blood cell transfusion in surgical treatment for periampullary or pancreatic carcinoma</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>
<B>Patient or population:</B> people with surgical treatment for periampullary or pancreatic carcinoma<BR/>
<B>Settings: </B>surgical departments in Asia and Europe<BR/>
<B>Intervention:</B> PPW</P>
<P>
<B>Comparison:</B> CW<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Illustrative comparative risks (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>CW vs PPW</B>
</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Intraoperative blood loss (millilitres)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Mean intraoperative blood loss in the intervention group was<BR/>
<B>320 millilitres lower</B>
</P>
<P>than in the control group<BR/>(620 to 30 lower)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>MD -0.32</B>
</P>
<P>
<B>(-0.62 to -0.03)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>404<BR/>(5 trials)</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Red blood cell transfusion (units)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Mean red blood cell transfusion in the intervention group was</P>
<P>
<B>0.47 units lower</B>
</P>
<P>than in the control group</P>
<P>(0.86 to 0.07 lower)</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>MD -0.47</B>
</P>
<P>
<B>(-0.86 to -0.07)</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>273</P>
<P>(5 trials)<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b</SUP>
<BR/>
</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Operating time </B>
</P>
<P>
<B>(minutes)</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean operating time in the intervention group was<BR/>
<B>45 minutes lower</B>
</P>
<P>than in the control group<BR/>(75 to 16 lower)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>MD -45.22</B>
</P>
<P>
<B>(-74.67 to -15.78)</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>472<BR/>(7 trials)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>a,b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>
<BR/>
<B>CI:</B> confidence interval; <B>CW:</B> classic Whipple; <B>MD:</B> mean difference; <B>PPW:</B> pylorus-preserving Whipple</P>
</TD>
</TR>
<TR>
<TD COLSPAN="6">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Serious limitations in the study design of <LINK REF="STD-Bloechle-1999" TYPE="STUDY">Bloechle 1999</LINK>, <LINK REF="STD-Lin-1999" TYPE="STUDY">Lin 1999</LINK>, <LINK REF="STD-Taher-2015" TYPE="STUDY">Taher 2015</LINK>, and <LINK REF="STD-Wenger-1999" TYPE="STUDY">Wenger 1999</LINK> are a potential source of bias. All are characterised by small sample sizes, lack of blinding, and incomplete outcome reporting.<BR/>
<SUP>b</SUP>The distribution of these continuous outcomes is known to be potentially skewed, which introduces a potential bias in the analyses.<BR/>
<SUP>c</SUP>Strong heterogeneity in the analyses.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2011-04-08 18:40:02 -0400" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2016-02-05 10:51:59 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Pancreatic fistula</NAME>
<DICH_OUTCOME CHI2="3.520534195784923" CI_END="1.8427949997706605" CI_START="0.48868588241999517" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9489720230765921" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.26547702517009475" LOG_CI_START="-0.3109702070648394" LOG_EFFECT_SIZE="-0.022746590947372313" METHOD="MH" MODIFIED="2015-12-03 10:07:47 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7412357853692833" P_Q="1.0" P_Z="0.8770734062330786" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="232" TOTAL_2="236" WEIGHT="100.0" Z="0.15468024316836249">
<NAME>Pancreatic fistula</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="24.229224130091904" CI_START="0.07912592466931531" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3843395073519216" LOG_CI_START="-1.101681201758983" LOG_EFFECT_SIZE="0.1413291527964693" MODIFIED="2015-12-02 07:51:06 -0500" MODIFIED_BY="[Empty name]" ORDER="14" O_E="0.0" SE="1.460300870532724" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="2.132478632478632" WEIGHT="5.37662358038779"/>
<DICH_DATA CI_END="7.891561130354871" CI_START="0.054572733504331825" EFFECT_SIZE="0.65625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.8971629250387329" LOG_CI_START="-1.2630242922107062" LOG_EFFECT_SIZE="-0.18293068358598671" MODIFIED="2015-12-02 07:51:05 -0500" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="1.268904664511502" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" VAR="1.6101190476190477" WEIGHT="7.120923708723464"/>
<DICH_DATA CI_END="113.00216844097272" CI_START="0.250458910572003" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0530867774030037" LOG_CI_START="-0.6012635128129075" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2015-12-03 10:07:47 -0500" MODIFIED_BY="[Empty name]" ORDER="16" O_E="0.0" SE="1.55917849971867" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="2.4310375939849624" WEIGHT="4.716313284675861"/>
<DICH_DATA CI_END="6.234519694297723" CI_START="0.2506207497313881" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.7948030011744754" LOG_CI_START="-0.6009829751583626" LOG_EFFECT_SIZE="0.09691001300805642" MODIFIED="2015-12-01 07:03:44 -0500" MODIFIED_BY="[Empty name]" ORDER="104" O_E="0.0" SE="0.8198915917499229" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" VAR="0.6722222222222223" WEIGHT="17.056167619920576"/>
<DICH_DATA CI_END="61.40281536491381" CI_START="0.08007489831495379" EFFECT_SIZE="2.217391304347826" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7881882843238288" LOG_CI_START="-1.0965036041631415" LOG_EFFECT_SIZE="0.3458423400803435" MODIFIED="2015-12-02 07:51:04 -0500" MODIFIED_BY="[Empty name]" ORDER="105" O_E="0.0" SE="1.6944822947523903" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" VAR="2.8712702472293263" WEIGHT="3.9931925290284167"/>
<DICH_DATA CI_END="2.064122904000069" CI_START="0.35528497223909145" EFFECT_SIZE="0.856359649122807" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.3147355529066775" LOG_CI_START="-0.4494231618089091" LOG_EFFECT_SIZE="-0.06734380445111585" ORDER="17" O_E="0.0" SE="0.4488706116705792" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" VAR="0.20148482602151987" WEIGHT="56.90520287037956"/>
<DICH_DATA CI_END="2.566984432898102" CI_START="0.006122452664929193" EFFECT_SIZE="0.12536443148688048" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.409423234964021" LOG_CI_START="-2.2130745638903893" LOG_EFFECT_SIZE="-0.9018256644631839" MODIFIED="2015-12-02 07:51:04 -0500" MODIFIED_BY="[Empty name]" ORDER="18" O_E="0.0" SE="1.540468188620549" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" VAR="2.3730422401518747" WEIGHT="4.831576406884324"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-02-05 10:52:09 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Delayed gastric emptying (with sensitivity analysis)</NAME>
<DICH_OUTCOME CHI2="22.302609798708914" CI_END="8.695361180049876" CI_START="1.0524740168360944" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="OR" EFFECT_SIZE="3.025168046407957" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="54" I2="73.09731886020201" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.9392876260448688" LOG_CI_START="0.022211382907708105" LOG_EFFECT_SIZE="0.48074950447628845" METHOD="MH" MODIFIED="2015-12-03 10:50:17 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0010670829169343587" P_Q="1.0" P_Z="0.03988830033893516" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.2475028947077758" TOTALS="YES" TOTAL_1="229" TOTAL_2="230" WEIGHT="99.99999999999999" Z="2.0549037692563514">
<NAME>All studies</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="27.483818324590164" CI_START="0.9340445642570266" EFFECT_SIZE="5.066666666666666" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.4390770690753631" LOG_CI_START="-0.02963240262514299" LOG_EFFECT_SIZE="0.7047223332251101" ORDER="19" O_E="0.0" SE="0.862727213906015" STUDY_ID="STD-Bloechle-1999" TOTAL_1="23" TOTAL_2="21" VAR="0.744298245614035" WEIGHT="14.569347894704373"/>
<DICH_DATA CI_END="591.3516816753661" CI_START="1.5040845137270984" EFFECT_SIZE="29.823529411764707" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.771845836187666" LOG_CI_START="0.17727223972245829" LOG_EFFECT_SIZE="1.4745590379550622" MODIFIED="2015-12-03 09:44:16 -0500" MODIFIED_BY="[Empty name]" ORDER="20" O_E="0.0" SE="1.5240653739101004" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="2.3227752639517343" WEIGHT="8.128006407577177"/>
<DICH_DATA CI_END="112.41669423871001" CI_START="1.2809485368269666" EFFECT_SIZE="12.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="2.0508308101421577" LOG_CI_START="0.10753168195309225" LOG_EFFECT_SIZE="1.0791812460476249" ORDER="21" O_E="0.0" SE="1.1415035273840826" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" VAR="1.303030303030303" WEIGHT="11.377716540271987"/>
<DICH_DATA CI_END="1.1172787293907134" CI_START="0.2662904549514443" EFFECT_SIZE="0.5454545454545454" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="30" LOG_CI_END="0.048161530802021846" LOG_CI_START="-0.5746444003511848" LOG_EFFECT_SIZE="-0.26324143477458145" ORDER="22" O_E="0.0" SE="0.3658392868984738" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="0.1338383838383838" WEIGHT="21.008018945875307"/>
<DICH_DATA CI_END="63.68859704392529" CI_START="1.5388940022089617" EFFECT_SIZE="9.9" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.8040616821908513" LOG_CI_START="0.18720870700424877" LOG_EFFECT_SIZE="0.9956351945975499" MODIFIED="2015-12-01 07:05:04 -0500" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.949747441175917" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" VAR="0.902020202020202" WEIGHT="13.50031725390189"/>
<DICH_DATA CI_END="39.15252674501436" CI_START="0.31287891276544244" EFFECT_SIZE="3.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5927597948998844" LOG_CI_START="-0.504623706199333" LOG_EFFECT_SIZE="0.5440680443502757" MODIFIED="2015-12-03 10:50:17 -0500" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="1.2320134507614529" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" VAR="1.5178571428571428" WEIGHT="10.493839267298696"/>
<DICH_DATA CI_END="2.061641907533126" CI_START="0.47691882572829575" EFFECT_SIZE="0.9915824915824916" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="18" LOG_CI_END="0.31421323364985515" LOG_CI_START="-0.32155553403803894" LOG_EFFECT_SIZE="-0.003671150194091914" ORDER="23" O_E="0.0" SE="0.3734537212460249" STUDY_ID="STD-Tran-2004" TOTAL_1="85" TOTAL_2="80" VAR="0.13946768191250364" WEIGHT="20.922753690370566"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.870840706451018" CI_END="7.219140978109024" CI_START="0.5542748007197775" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="2.0003469516584764" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="50" I2="78.37189494502113" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.8584855229626676" LOG_CI_START="-0.25627486551202916" LOG_EFFECT_SIZE="0.3011053287253192" METHOD="MH" MODIFIED="2015-12-03 09:44:43 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0030863497138180485" P_Q="1.0" P_Z="0.2896897041453309" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.1483849870273417" TOTALS="YES" TOTAL_1="177" TOTAL_2="178" WEIGHT="100.0" Z="1.0588026018079402">
<NAME>Studies in which DGE was defined (includes different definitions)</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="591.3516816753661" CI_START="1.5040845137270984" EFFECT_SIZE="29.823529411764707" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.771845836187666" LOG_CI_START="0.17727223972245829" LOG_EFFECT_SIZE="1.4745590379550622" MODIFIED="2015-12-03 09:44:43 -0500" MODIFIED_BY="[Empty name]" ORDER="24" O_E="0.0" SE="1.5240653739101004" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="2.3227752639517343" WEIGHT="12.352748420903222"/>
<DICH_DATA CI_END="1.1172787293907134" CI_START="0.2662904549514443" EFFECT_SIZE="0.5454545454545454" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="30" LOG_CI_END="0.048161530802021846" LOG_CI_START="-0.5746444003511848" LOG_EFFECT_SIZE="-0.26324143477458145" ORDER="25" O_E="0.0" SE="0.3658392868984738" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="0.1338383838383838" WEIGHT="33.440639348223236"/>
<DICH_DATA CI_END="63.68859704392529" CI_START="1.5388940022089617" EFFECT_SIZE="9.9" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.8040616821908513" LOG_CI_START="0.18720870700424877" LOG_EFFECT_SIZE="0.9956351945975499" MODIFIED="2015-12-01 07:08:07 -0500" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.949747441175917" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" VAR="0.902020202020202" WEIGHT="20.912144359574956"/>
<DICH_DATA CI_END="2.061641907533126" CI_START="0.47691882572829575" EFFECT_SIZE="0.9915824915824916" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="18" LOG_CI_END="0.31421323364985515" LOG_CI_START="-0.32155553403803894" LOG_EFFECT_SIZE="-0.003671150194091914" ORDER="26" O_E="0.0" SE="0.3734537212460249" STUDY_ID="STD-Tran-2004" TOTAL_1="85" TOTAL_2="80" VAR="0.13946768191250364" WEIGHT="33.294467871298586"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.011619108310958" CI_END="119.16197080611985" CI_START="0.13589523874429515" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="4.024120335171203" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="18" I2="80.04636868069917" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="2.0761376773488536" LOG_CI_START="-0.8667957590386819" LOG_EFFECT_SIZE="0.604670959155086" METHOD="MH" MODIFIED="2015-12-03 09:44:49 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.02517777697625001" P_Q="1.0" P_Z="0.42058340755608836" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="4.938790425466422" TOTALS="YES" TOTAL_1="99" TOTAL_2="99" WEIGHT="100.0" Z="0.8054095194867984">
<NAME>Studies with the same definitions of DGE</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="591.3516816753661" CI_START="1.5040845137270984" EFFECT_SIZE="29.823529411764707" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.771845836187666" LOG_CI_START="0.17727223972245829" LOG_EFFECT_SIZE="1.4745590379550622" MODIFIED="2015-12-03 09:44:49 -0500" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="1.5240653739101004" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="2.3227752639517343" WEIGHT="41.1534085980793"/>
<DICH_DATA CI_END="2.061641907533126" CI_START="0.47691882572829575" EFFECT_SIZE="0.9915824915824916" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="18" LOG_CI_END="0.31421323364985515" LOG_CI_START="-0.32155553403803894" LOG_EFFECT_SIZE="-0.003671150194091914" ORDER="28" O_E="0.0" SE="0.3734537212460249" STUDY_ID="STD-Tran-2004" TOTAL_1="85" TOTAL_2="80" VAR="0.13946768191250364" WEIGHT="58.84659140192069"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2016-02-05 10:52:17 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Biliary leakage</NAME>
<DICH_OUTCOME CHI2="4.78360152463123" CI_END="6.170256785206352" CI_START="0.14805577963757932" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9557940044265765" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" I2="37.285746219606544" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.7903032382759597" LOG_CI_START="-0.8295746344366888" LOG_EFFECT_SIZE="-0.019635698080364496" METHOD="MH" MODIFIED="2015-12-01 07:10:08 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.188346328366627" P_Q="1.0" P_Z="0.9621017792713434" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.3498078424491045" TOTALS="YES" TOTAL_1="191" TOTAL_2="189" WEIGHT="100.0" Z="0.04751625007923503">
<NAME>Biliary leakage</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="29" O_E="0.0" SE="0.0" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.463760566702005" CI_START="0.013538086737645089" EFFECT_SIZE="0.3385012919896641" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9275633690069292" LOG_CI_START="-1.8684427077332233" LOG_EFFECT_SIZE="-0.47043966936314713" ORDER="30" O_E="0.0" SE="1.6423878099304614" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="2.6974377182081777" WEIGHT="22.370731987464975"/>
<DICH_DATA CI_END="123.80523719411805" CI_START="0.23553123164151077" EFFECT_SIZE="5.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.092739016545149" LOG_CI_START="-0.6279514968992119" LOG_EFFECT_SIZE="0.7323937598229685" MODIFIED="2015-12-01 07:09:56 -0500" MODIFIED_BY="[Empty name]" ORDER="109" O_E="0.0" SE="1.5981470752324625" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" VAR="2.554074074074074" WEIGHT="23.192260334953176"/>
<DICH_DATA CI_END="1.8419440063117745" CI_START="0.012463376226418018" EFFECT_SIZE="0.15151515151515152" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.26527642384159317" LOG_CI_START="-1.9043642949253303" LOG_EFFECT_SIZE="-0.8195439355418687" MODIFIED="2015-12-01 07:10:08 -0500" MODIFIED_BY="[Empty name]" ORDER="110" O_E="0.0" SE="1.2744576980984594" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" VAR="1.624242424242424" WEIGHT="30.44328024275199"/>
<DICH_DATA CI_END="103.2412906088213" CI_START="0.2309549661656029" EFFECT_SIZE="4.883040935672515" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0138534249766935" LOG_CI_START="-0.6364726947937971" LOG_EFFECT_SIZE="0.6886903650914483" ORDER="31" O_E="0.0" SE="1.556814682079065" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" VAR="2.42367195433694" WEIGHT="23.993727434829854"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2016-02-07 10:35:53 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Survival</NAME>
<IV_OUTCOME CHI2="2.2092375869652323" CI_END="1.1561973437356103" CI_START="0.6108598589154087" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="0.8404014197231614" ESTIMABLE="YES" I2="9.47103146351299" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.06303196728586008" LOG_CI_START="-0.21405841247530283" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.07551322259472137" MODIFIED="2016-02-07 10:31:57 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.33133744031355516" P_Q="1.0" P_Z="0.2854002936217549" Q="0.0" RANDOM="YES" SCALE="5.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.008317695139174842" TOTALS="YES" TOTAL_1="138" TOTAL_2="146" WEIGHT="100.00000000000001" Z="1.0682665834142706">
<NAME>Overall</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.2360309902592412" CI_START="0.2531671258779901" EFFECT_SIZE="0.5593946847263193" ESTIMABLE="YES" ESTIMATE="-0.5809" LOG_CI_END="0.09202935969281029" LOG_CI_START="-0.5965926887680083" LOG_EFFECT_SIZE="-0.252281664537599" MODIFIED="2016-02-07 10:30:06 -0500" MODIFIED_BY="[Empty name]" ORDER="1" SE="0.4045" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" WEIGHT="15.408003472945714"/>
<IV_DATA CI_END="1.2567061097271899" CI_START="0.4278023028466553" EFFECT_SIZE="0.7332269551392347" ESTIMABLE="YES" ESTIMATE="-0.3103" LOG_CI_END="0.09923372649518479" LOG_CI_START="-0.36875688196434286" LOG_EFFECT_SIZE="-0.13476157773457903" MODIFIED="2016-02-07 10:31:07 -0500" MODIFIED_BY="[Empty name]" ORDER="2" SE="0.2749" STUDY_ID="STD-Seiler-2005" TOTAL_1="53" TOTAL_2="57" WEIGHT="31.580557024898194"/>
<IV_DATA CI_END="1.5307053607184014" CI_START="0.6877508458868227" EFFECT_SIZE="1.0260330923696246" ESTIMABLE="YES" ESTIMATE="0.0257" LOG_CI_END="0.18489160315506567" LOG_CI_START="-0.16256886678523855" LOG_EFFECT_SIZE="0.011161368184913577" MODIFIED="2016-02-07 10:31:57 -0500" MODIFIED_BY="[Empty name]" ORDER="3" SE="0.2041" STUDY_ID="STD-Tran-2004" TOTAL_1="68" TOTAL_2="66" WEIGHT="53.0114395021561"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="5.201465813177501" CI_END="1.2180683245729336" CI_START="0.43292896622891136" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_SIZE="0.7261797715122216" ESTIMABLE="YES" I2="61.54930029659796" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.08567164967023176" LOG_CI_START="-0.36358335562245453" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.13895585297611132" MODIFIED="2016-02-07 10:35:02 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.07421927647549698" P_Q="1.0" P_Z="0.22534214939417263" Q="0.0" RANDOM="YES" SCALE="10.0" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.12534024772656008" TOTALS="YES" TOTAL_1="98" TOTAL_2="105" WEIGHT="99.99999999999999" Z="1.2124448879397045">
<NAME>Pancreatic head carcinoma</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard ratio</EFFECT_MEASURE>
<IV_DATA CI_END="1.0218180400115422" CI_START="0.1683713313782434" EFFECT_SIZE="0.4147829116815814" ESTIMABLE="YES" ESTIMATE="-0.88" LOG_CI_END="0.009373565803972141" LOG_CI_START="-0.7737318539536954" LOG_EFFECT_SIZE="-0.3821791440748616" MODIFIED="2016-02-07 10:32:58 -0500" MODIFIED_BY="[Empty name]" ORDER="4" SE="0.46" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" WEIGHT="20.668462062764508"/>
<IV_DATA CI_END="1.0819769917818063" CI_START="0.36103155457606617" EFFECT_SIZE="0.6250022682827008" ESTIMABLE="YES" ESTIMATE="-0.47" LOG_CI_END="0.034218025605631336" LOG_CI_START="-0.44245483859468804" LOG_EFFECT_SIZE="-0.20411840649452836" MODIFIED="2016-02-07 10:33:35 -0500" MODIFIED_BY="[Empty name]" ORDER="5" SE="0.28" STUDY_ID="STD-Seiler-2005" TOTAL_1="37" TOTAL_2="43" WEIGHT="34.180957396799286"/>
<IV_DATA CI_END="1.466962413317006" CI_START="0.7533737115845405" EFFECT_SIZE="1.0512710963760241" ESTIMABLE="YES" ESTIMATE="0.05" LOG_CI_END="0.1664189864416881" LOG_CI_START="-0.12298953825136293" LOG_EFFECT_SIZE="0.021714724095162622" MODIFIED="2016-02-07 10:35:02 -0500" MODIFIED_BY="[Empty name]" ORDER="6" SE="0.17" STUDY_ID="STD-Tran-2004" TOTAL_1="47" TOTAL_2="43" WEIGHT="45.1505805404362"/>
</IV_OUTCOME>
<IV_OUTCOME CHI2="0.04300470443853548" CI_END="1.7593714871731063" CI_START="0.3916043857808392" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_SIZE="0.830046740006095" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.24535754940370522" LOG_CI_START="-0.40715245295227237" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.08089745177428359" MODIFIED="2016-02-07 10:35:53 -0500" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8357165377250015" P_Q="1.0" P_Z="0.6269755097272565" Q="0.0" RANDOM="YES" SCALE="19.87" SHOW_PARTICIPANTS="YES" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="37" TOTAL_2="37" WEIGHT="100.00000000000001" Z="0.4859882341915773">
<NAME>Periampullary cancer</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<EFFECT_MEASURE>Hazard ratio</EFFECT_MEASURE>
<IV_DATA CI_END="14.974544696272073" CI_START="0.07836704853430082" EFFECT_SIZE="1.0832870676749586" ESTIMABLE="YES" ESTIMATE="0.08" LOG_CI_END="1.1753536264601674" LOG_CI_START="-1.105866509355647" LOG_EFFECT_SIZE="0.034743558552260176" MODIFIED="2016-02-07 10:35:50 -0500" MODIFIED_BY="[Empty name]" ORDER="7" SE="1.34" STUDY_ID="STD-Seiler-2005" TOTAL_1="16" TOTAL_2="14" WEIGHT="8.18163223563101"/>
<IV_DATA CI_END="1.775328708760048" CI_START="0.3700986845832969" EFFECT_SIZE="0.8105842459701871" ESTIMABLE="YES" ESTIMATE="-0.21" LOG_CI_END="0.2492787760862595" LOG_CI_START="-0.43168245848562525" LOG_EFFECT_SIZE="-0.0912018411996829" MODIFIED="2016-02-07 10:35:53 -0500" MODIFIED_BY="[Empty name]" ORDER="8" SE="0.4" STUDY_ID="STD-Tran-2004" TOTAL_1="21" TOTAL_2="23" WEIGHT="91.818367764369"/>
</IV_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2016-02-05 10:53:15 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Postoperative mortality</NAME>
<DICH_OUTCOME CHI2="2.395699178825267" CI_END="1.542470940258188" CI_START="0.26443869829045646" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6386618883202063" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.18821699078994897" LOG_CI_START="-0.5776749893369058" LOG_EFFECT_SIZE="-0.19472899927347842" METHOD="MH" MODIFIED="2015-12-28 07:27:41 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7921144445940489" P_Q="1.0" P_Z="0.31893608338025614" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="231" TOTAL_2="233" WEIGHT="100.0" Z="0.996646616558981">
<NAME>Postoperative mortality</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="9" O_E="0.0" SE="0.0" STUDY_ID="STD-Bloechle-1999" TOTAL_1="23" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.019197992092439" CI_START="0.05331141509674304" EFFECT_SIZE="0.6538461538461539" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.9041309362361074" LOG_CI_START="-1.2731797894211954" LOG_EFFECT_SIZE="-0.18452442659254403" ORDER="10" O_E="0.0" SE="1.278963098113015" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="1.6357466063348416" WEIGHT="12.373547217675936"/>
<DICH_DATA CI_END="11.175278649379841" CI_START="0.016435694818039078" EFFECT_SIZE="0.42857142857142855" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.048258360831205" LOG_CI_START="-1.7842119314203941" LOG_EFFECT_SIZE="-0.36797678529459443" MODIFIED="2015-12-28 07:27:41 -0500" MODIFIED_BY="[Empty name]" ORDER="11" O_E="0.0" SE="1.663807070622663" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" VAR="2.7682539682539677" WEIGHT="7.311463507953855"/>
<DICH_DATA CI_END="5.743847465869909" CI_START="0.04491753961569731" EFFECT_SIZE="0.5079365079365079" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7592028982240432" LOG_CI_START="-1.3475840404913946" LOG_EFFECT_SIZE="-0.29419057113367575" ORDER="12" O_E="0.0" SE="1.2375370765649876" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="1.5314980158730158" WEIGHT="13.215810702895178"/>
<DICH_DATA CI_END="14.726249915011564" CI_START="0.3286648011498316" EFFECT_SIZE="2.2" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.1680921664917279" LOG_CI_START="-0.48324680484731536" LOG_EFFECT_SIZE="0.3424226808222063" MODIFIED="2015-12-02 06:22:09 -0500" MODIFIED_BY="[Empty name]" ORDER="102" O_E="0.0" SE="0.9700046860242949" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" VAR="0.9409090909090909" WEIGHT="21.51109821893823"/>
<DICH_DATA CI_END="5.566303928046948" CI_START="0.0071860970074688" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7455669157368101" LOG_CI_START="-2.1435069244088476" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2015-12-01 07:01:59 -0500" MODIFIED_BY="[Empty name]" ORDER="103" O_E="0.0" SE="1.697056274847714" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" VAR="2.88" WEIGHT="7.027773565846296"/>
<DICH_DATA CI_END="1.896146910931508" CI_START="0.11078753615206165" EFFECT_SIZE="0.4583333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.2778719828623591" LOG_CI_START="-0.955509095969121" LOG_EFFECT_SIZE="-0.338818556553381" ORDER="13" O_E="0.0" SE="0.7244941510404173" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" VAR="0.5248917748917749" WEIGHT="38.56030678669051"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2015-12-29 13:20:06 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Intraoperative blood loss</NAME>
<CONT_OUTCOME CHI2="23.540163851304616" CI_END="-0.030632210444046737" CI_START="-0.6165652957823564" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3235987531132016" ESTIMABLE="YES" I2="83.00776483432033" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2015-12-29 13:20:06 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="9.87446118004831E-5" P_Q="1.0" P_Z="0.030395701548245318" Q="0.0" RANDOM="YES" SCALE="1.1113630549099953" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.08095186481537792" TOTALS="YES" TOTAL_1="202" TOTAL_2="202" UNITS="" WEIGHT="100.0" Z="2.1648953350287137">
<NAME>Intraoperative blood loss (litres)</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.11541281225220201" CI_START="-0.384587187747798" EFFECT_SIZE="-0.25" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.25" MODIFIED="2015-12-29 13:18:19 -0500" MODIFIED_BY="[Empty name]" ORDER="78" SD_1="0.2" SD_2="0.25" SE="0.06866819431857143" STUDY_ID="STD-Bloechle-1999" TOTAL_1="23" TOTAL_2="21" WEIGHT="26.081067901563262"/>
<CONT_DATA CI_END="-0.5667437190825084" CI_START="-0.9652562809174916" EFFECT_SIZE="-0.766" ESTIMABLE="YES" MEAN_1="0.446" MEAN_2="1.212" MODIFIED="2015-12-03 09:58:32 -0500" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="0.342" SD_2="0.194" SE="0.10166323590086333" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" WEIGHT="24.4753894328811"/>
<CONT_DATA CI_END="0.10135858660715336" CI_START="-0.7053585866071534" EFFECT_SIZE="-0.30200000000000005" ESTIMABLE="YES" MEAN_1="1.198" MEAN_2="1.5" MODIFIED="2015-12-03 10:09:50 -0500" MODIFIED_BY="[Empty name]" ORDER="179" SD_1="0.9" SD_2="1.4" SE="0.20579897885307813" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" WEIGHT="18.120028843101377"/>
<CONT_DATA CI_END="0.2026396503269302" CI_START="-0.3486396503269301" EFFECT_SIZE="-0.07299999999999995" ESTIMABLE="YES" MEAN_1="1.85" MEAN_2="1.923" MODIFIED="2015-12-01 12:21:01 -0500" MODIFIED_BY="[Empty name]" ORDER="111" SD_1="0.318" SD_2="0.404" SE="0.14063505885880584" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" WEIGHT="22.18097698254528"/>
<CONT_DATA CI_END="0.7923500759386973" CI_START="-0.7923500759386973" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.0" MODIFIED="2015-12-01 12:21:02 -0500" MODIFIED_BY="[Empty name]" ORDER="183" SD_1="3.43" SD_2="1.53" SE="0.4042676713391948" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" WEIGHT="9.142536839908987"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2015-12-29 13:21:05 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Red blood cell transfusion</NAME>
<CONT_OUTCOME CHI2="3.812027202741341" CI_END="-0.07455178904677773" CI_START="-0.8563190818793485" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.4654354354630631" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2015-12-29 13:21:05 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4320426036945295" P_Q="1.0" P_Z="0.0196072104892962" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="139" TOTAL_2="134" UNITS="" WEIGHT="99.99999999999999" Z="2.3337806505847056">
<NAME>Red blood cell transfusion</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0523788893122559" CI_START="-1.0523788893122559" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.0" MODIFIED="2015-12-29 13:20:52 -0500" MODIFIED_BY="[Empty name]" ORDER="80" SD_1="1.5" SD_2="2.0" SE="0.5369378711105338" STUDY_ID="STD-Bloechle-1999" TOTAL_1="23" TOTAL_2="21" WEIGHT="13.795922529057583"/>
<CONT_DATA CI_END="0.8838450550493864" CI_START="-2.0838450550493866" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.6" MODIFIED="2011-03-10 12:30:31 -0500" MODIFIED_BY="Karin L Dearness" ORDER="51" SD_1="1.4" SD_2="2.6" SE="0.7570777150773008" STUDY_ID="STD-Lin-1999" TOTAL_1="16" TOTAL_2="15" WEIGHT="6.9393356517811515"/>
<CONT_DATA CI_END="-0.29372399431917795" CI_START="-1.706276005680822" EFFECT_SIZE="-0.9999999999999999" ESTIMABLE="YES" MEAN_1="0.9" MEAN_2="1.9" MODIFIED="2015-12-01 09:06:46 -0500" MODIFIED_BY="[Empty name]" ORDER="180" SD_1="1.5" SD_2="2.5" SE="0.36035152240134866" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" WEIGHT="30.629936582969314"/>
<CONT_DATA CI_END="0.3661371835464291" CI_START="-0.786137183546429" EFFECT_SIZE="-0.20999999999999996" ESTIMABLE="YES" MEAN_1="2.67" MEAN_2="2.88" MODIFIED="2015-12-01 07:15:37 -0500" MODIFIED_BY="[Empty name]" ORDER="112" SD_1="0.65" SD_2="0.64" SE="0.2939529440800574" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" WEIGHT="46.03023494353434"/>
<CONT_DATA CI_END="1.6220296738001214" CI_START="-3.222029673800121" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="6.3" ORDER="34" SD_1="3.1" SD_2="5.2" SE="1.2357521326436518" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" WEIGHT="2.604570292657613"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2015-12-29 13:23:04 -0500" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Operating time</NAME>
<CONT_OUTCOME CHI2="38.11571467455617" CI_END="-15.77538739542355" CI_START="-74.67015380611838" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-45.222770600770964" ESTIMABLE="YES" I2="84.25846123776016" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2015-12-29 13:23:04 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0663435195956694E-6" P_Q="1.0" P_Z="0.0026129506463183224" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="1271.8857655846991" TOTALS="YES" TOTAL_1="238" TOTAL_2="234" UNITS="" WEIGHT="99.99999999999999" Z="3.00994492585448">
<NAME>Operating time (minutes)</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.568634168078582" CI_START="-96.56863416807857" EFFECT_SIZE="-46.0" ESTIMABLE="YES" MEAN_1="239.0" MEAN_2="285.0" ORDER="35" SD_1="79.0" SD_2="91.0" SE="25.800797650853543" STUDY_ID="STD-Bloechle-1999" TOTAL_1="23" TOTAL_2="21" WEIGHT="11.650391551626408"/>
<CONT_DATA CI_END="-15.498597429855216" CI_START="-84.50140257014479" EFFECT_SIZE="-50.0" ESTIMABLE="YES" MEAN_1="221.0" MEAN_2="271.0" ORDER="36" SD_1="35.0" SD_2="65.0" SE="17.603079874062708" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" WEIGHT="14.271126022291716"/>
<CONT_DATA CI_END="-26.09695619947692" CI_START="-107.90304380052308" EFFECT_SIZE="-67.0" ESTIMABLE="YES" MEAN_1="382.0" MEAN_2="449.0" MODIFIED="2015-12-01 09:09:24 -0500" MODIFIED_BY="[Empty name]" ORDER="181" SD_1="101.0" SD_2="135.0" SE="20.869283376205413" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" WEIGHT="13.220829748391495"/>
<CONT_DATA CI_END="6.597262555286381" CI_START="-36.59726255528638" EFFECT_SIZE="-15.0" ESTIMABLE="YES" MEAN_1="305.0" MEAN_2="320.0" MODIFIED="2015-12-01 09:09:23 -0500" MODIFIED_BY="[Empty name]" ORDER="113" SD_1="35.0" SD_2="21.0" SE="11.019213988442049" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" WEIGHT="16.201299127018853"/>
<CONT_DATA CI_END="-6.309472831590433" CI_START="-89.69052716840957" EFFECT_SIZE="-48.0" ESTIMABLE="YES" MEAN_1="308.0" MEAN_2="356.0" MODIFIED="2015-12-01 09:09:22 -0500" MODIFIED_BY="[Empty name]" ORDER="114" SD_1="46.0" SD_2="47.0" SE="21.27106798760545" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" WEIGHT="13.091014344499412"/>
<CONT_DATA CI_END="19.966099140406413" CI_START="-19.966099140406413" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="300.0" MEAN_2="300.0" MODIFIED="2015-12-01 12:23:40 -0500" MODIFIED_BY="[Empty name]" ORDER="184" SD_1="78.0" SD_2="53.0" SE="10.186972463727116" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" WEIGHT="16.40914941612999"/>
<CONT_DATA CI_END="-71.09468399236962" CI_START="-128.90531600763038" EFFECT_SIZE="-100.0" ESTIMABLE="YES" MEAN_1="206.0" MEAN_2="306.0" ORDER="37" SD_1="48.0" SD_2="54.0" SE="14.747881203752625" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" WEIGHT="15.156189790042117"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2015-12-01 07:21:03 -0500" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Postoperative bleeding</NAME>
<DICH_OUTCOME CHI2="0.5145448374566536" CI_END="1.7396234038223013" CI_START="0.3187448203815618" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.744644847818677" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="0.24045524176319344" LOG_CI_START="-0.49655686380656266" LOG_EFFECT_SIZE="-0.1280508110216846" METHOD="MH" MODIFIED="2015-12-01 07:21:03 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9720696904530778" P_Q="1.0" P_Z="0.4958331089629193" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="191" TOTAL_2="189" WEIGHT="100.0" Z="0.6810606661599601">
<NAME>Postoperative bleeding</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.230249573595092" CI_START="0.016105549058543143" EFFECT_SIZE="0.42528735632183906" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.050389407840335" LOG_CI_START="-1.793024464943582" LOG_EFFECT_SIZE="-0.37131752855162353" ORDER="38" O_E="0.0" SE="1.670235383998944" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="2.7896862379621" WEIGHT="6.7184499570068175"/>
<DICH_DATA CI_END="2.8302071417668673" CI_START="0.08833275710127977" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4518182225328251" LOG_CI_START="-1.0538782138607876" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="39" O_E="0.0" SE="0.8844535400551738" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="0.782258064516129" WEIGHT="23.95931500826674"/>
<DICH_DATA CI_END="16.45575502716643" CI_START="0.05177951449268024" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.216317813498181" LOG_CI_START="-1.2858420260166048" LOG_EFFECT_SIZE="-0.03476210625921192" MODIFIED="2015-12-01 07:21:02 -0500" MODIFIED_BY="[Empty name]" ORDER="115" O_E="0.0" SE="1.4697810756219478" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" VAR="2.16025641025641" WEIGHT="8.675992024147897"/>
<DICH_DATA CI_END="11.909492696108071" CI_START="0.0340030165867844" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0758932624086153" LOG_CI_START="-1.4684825526965517" LOG_EFFECT_SIZE="-0.19629464514396822" MODIFIED="2015-12-01 07:21:03 -0500" MODIFIED_BY="[Empty name]" ORDER="116" O_E="0.0" SE="1.4945789486561871" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" VAR="2.2337662337662336" WEIGHT="8.390478422578033"/>
<DICH_DATA CI_END="3.0745355541173174" CI_START="0.29392186385207963" EFFECT_SIZE="0.9506172839506173" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.48777951961767463" LOG_CI_START="-0.5317681070300104" LOG_EFFECT_SIZE="-0.021994293706167876" ORDER="40" O_E="0.0" SE="0.5988873227349966" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" VAR="0.358666025332692" WEIGHT="52.25576458800051"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2015-12-03 11:24:40 -0500" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Wound infection</NAME>
<DICH_OUTCOME CHI2="0.32732389261873057" CI_END="2.0491098307591535" CI_START="0.3527984871551386" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8502486979152344" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-010.01" LOG_CI_END="0.31156523688548404" LOG_CI_START="-0.45247328584629487" LOG_EFFECT_SIZE="-0.07045402448040541" METHOD="MH" NO="1" P_CHI2="0.9548102899456655" P_Q="1.0" P_Z="0.7177503819469517" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="132" WEIGHT="100.00000000000001" Z="0.36146698481582834">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="24.229224130091904" CI_START="0.07912592466931531" EFFECT_SIZE="1.3846153846153846" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3843395073519216" LOG_CI_START="-1.101681201758983" LOG_EFFECT_SIZE="0.1413291527964693" ORDER="41" O_E="0.0" SE="1.460300870532724" STUDY_ID="STD-Lin-1999" TOTAL_1="14" TOTAL_2="19" VAR="2.132478632478632" WEIGHT="9.445414654169369"/>
<DICH_DATA CI_END="3.9378577267151296" CI_START="0.10186023440864857" EFFECT_SIZE="0.6333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.5952600211929766" LOG_CI_START="-0.9919953287266436" LOG_EFFECT_SIZE="-0.1983676537668335" ORDER="42" O_E="0.0" SE="0.9323616495834838" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" VAR="0.869298245614035" WEIGHT="23.17058043835022"/>
<DICH_DATA CI_END="4.320726271967456" CI_START="0.2471292348940129" EFFECT_SIZE="1.0333333333333334" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.635556753619813" LOG_CI_START="-0.6070758753905924" LOG_EFFECT_SIZE="0.014240439114610285" ORDER="43" O_E="0.0" SE="0.7299285574114299" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="0.5327956989247311" WEIGHT="37.80463124151879"/>
<DICH_DATA CI_END="3.599830948521582" CI_START="0.14173001147239686" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5562821063650373" LOG_CI_START="-0.8485381777215133" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="44" O_E="0.0" SE="0.8251983888449983" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" VAR="0.680952380952381" WEIGHT="29.57937366596163"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2008-05-09 18:10:56 -0400" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Pulmonary complications</NAME>
<DICH_OUTCOME CHI2="0.005458435668122019" CI_END="1.5779387634628734" CI_START="0.2872204057713915" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6732133479991423" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-011.01" LOG_CI_END="0.19809014513056203" LOG_CI_START="-0.541784708583291" LOG_EFFECT_SIZE="-0.17184728172636446" METHOD="MH" MODIFIED="2008-05-09 18:10:56 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9972745030973934" P_Q="1.0" P_Z="0.3625781918896097" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="105" TOTAL_2="113" WEIGHT="100.0" Z="0.9104633880557476">
<NAME>Pulmonary complications</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.891561130354871" CI_START="0.054572733504331825" EFFECT_SIZE="0.65625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.8971629250387329" LOG_CI_START="-1.2630242922107062" LOG_EFFECT_SIZE="-0.18293068358598671" ORDER="45" O_E="0.0" SE="1.268904664511502" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" VAR="1.6101190476190477" WEIGHT="11.7309653103357"/>
<DICH_DATA CI_END="1.9338445222209057" CI_START="0.24456869605849998" EFFECT_SIZE="0.6877192982456141" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.28642155461987906" LOG_CI_START="-0.6115991319239473" LOG_EFFECT_SIZE="-0.16258878865203413" ORDER="46" O_E="0.0" SE="0.5275017965499345" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="0.2782581453634085" WEIGHT="67.88031548352886"/>
<DICH_DATA CI_END="4.197465539084697" CI_START="0.09647695113043286" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.6229871392956629" LOG_CI_START="-1.0155764295835994" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="47" O_E="0.0" SE="0.9625003513801573" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" VAR="0.9264069264069263" WEIGHT="20.38871920613544"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2015-12-01 12:35:57 -0500" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Necessity for reoperation</NAME>
<DICH_OUTCOME CHI2="0.6719775452325731" CI_END="1.679412549591753" CI_START="0.38402029934176624" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8030744112549868" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-012.01" LOG_CI_END="0.2251573941743771" LOG_CI_START="-0.41564581818687835" LOG_EFFECT_SIZE="-0.09524421200625066" METHOD="MH" MODIFIED="2015-12-01 12:35:57 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7146312007355021" P_Q="1.0" P_Z="0.5601431701390794" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="163" TOTAL_2="157" WEIGHT="100.0" Z="0.5826288684798594">
<NAME>Necessity for reoperation</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<DICH_DATA CI_END="23.711034807642875" CI_START="0.18541839503830346" EFFECT_SIZE="2.096774193548387" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3749505080668547" LOG_CI_START="-0.7318471824496888" LOG_EFFECT_SIZE="0.3215516628085829" ORDER="48" O_E="0.0" SE="1.2375433922261796" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="1.5315136476426798" WEIGHT="9.251319784565872"/>
<DICH_DATA CI_END="11.909492696108071" CI_START="0.0340030165867844" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0758932624086153" LOG_CI_START="-1.4684825526965517" LOG_EFFECT_SIZE="-0.19629464514396822" MODIFIED="2015-12-01 12:35:57 -0500" MODIFIED_BY="[Empty name]" ORDER="117" O_E="0.0" SE="1.4945789486561871" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" VAR="2.2337662337662336" WEIGHT="6.342885076600241"/>
<DICH_DATA CI_END="1.6421465186055697" CI_START="0.3295497612270409" EFFECT_SIZE="0.7356418918918919" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.21541190393022788" LOG_CI_START="-0.4820789986887034" LOG_EFFECT_SIZE="-0.13333354737923778" ORDER="49" O_E="0.0" SE="0.4097096088340116" STUDY_ID="STD-Tran-2004" TOTAL_1="87" TOTAL_2="83" VAR="0.1678619635709188" WEIGHT="84.40579513883388"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2016-02-07 10:12:43 -0500" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Duration of hospital stay</NAME>
<CONT_OUTCOME CHI2="3.080026056969963" CI_END="2.5625697701036585" CI_START="-2.035441672032873" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.26356404903539277" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.01" MODIFIED="2015-12-01 12:36:23 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5445237865515475" P_Q="1.0" P_Z="0.8222162321709726" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="188" TOTAL_2="178" UNITS="" WEIGHT="100.0" Z="0.2246954146285831">
<NAME>Hospital stay (days)</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PPW</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours CW</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.6521701939176587" CI_START="-5.852170193917662" EFFECT_SIZE="-1.1000000000000014" ESTIMABLE="YES" MEAN_1="19.7" MEAN_2="20.8" MODIFIED="2015-12-01 12:36:20 -0500" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="12.8" SD_2="14.8" SE="2.4246211825330324" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" WEIGHT="23.40432563028927"/>
<CONT_DATA CI_END="5.413759091549628" CI_START="-1.0137590915496295" EFFECT_SIZE="2.1999999999999993" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="18.8" MODIFIED="2015-12-01 12:36:21 -0500" MODIFIED_BY="[Empty name]" ORDER="118" SD_1="4.7" SD_2="3.8" SE="1.6397031358225713" STUDY_ID="STD-Srinarmwong-2008" TOTAL_1="14" TOTAL_2="13" WEIGHT="51.174483437418374"/>
<CONT_DATA CI_END="4.1575918494294015" CI_START="-10.557591849429407" EFFECT_SIZE="-3.200000000000003" ESTIMABLE="YES" MEAN_1="24.9" MEAN_2="28.1" MODIFIED="2015-12-01 12:36:22 -0500" MODIFIED_BY="[Empty name]" ORDER="119" SD_1="6.7" SD_2="9.1" SE="3.753942372138034" STUDY_ID="STD-Taher-2015" TOTAL_1="12" TOTAL_2="8" WEIGHT="9.763571685749026"/>
<CONT_DATA CI_END="8.007240164764683" CI_START="-12.007240164764683" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="20.0" MODIFIED="2015-12-01 12:36:23 -0500" MODIFIED_BY="[Empty name]" ORDER="185" SD_1="28.5" SD_2="31.8" SE="5.105828598739832" STUDY_ID="STD-Tran-2004" TOTAL_1="74" TOTAL_2="67" WEIGHT="5.277782136439984"/>
<CONT_DATA CI_END="5.335834728757571" CI_START="-8.935834728757566" EFFECT_SIZE="-1.7999999999999972" ESTIMABLE="YES" MEAN_1="19.1" MEAN_2="20.9" ORDER="50" SD_1="11.3" SD_2="13.8" SE="3.640798905002399" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" WEIGHT="10.379837110103345"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" NO="14">
<NAME>R0 resection rate</NAME>
<DICH_OUTCOME CHI2="2.318466058219147" CI_END="2.1473938974058795" CI_START="0.39142064283690975" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9168065770633773" ESTIMABLE="YES" EVENTS_1="142" EVENTS_2="149" I2="56.8680336529008" I2_Q="0.0" ID="CMP-014.01" LOG_CI_END="0.33191171457102253" LOG_CI_START="-0.4073562741461946" LOG_EFFECT_SIZE="-0.037722279787585994" METHOD="MH" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1278461820907224" P_Q="1.0" P_Z="0.8414646893716984" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.21461416938744268" TOTALS="YES" TOTAL_1="177" TOTAL_2="182" WEIGHT="100.0" Z="0.20002031990240285">
<NAME>R0 resection rate</NAME>
<GROUP_LABEL_1>PPW</GROUP_LABEL_1>
<GROUP_LABEL_2>CW</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours [PPWexperimental]</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours [CWcontrol]</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="17" EVENTS_2="23" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-07 10:12:33 -0500" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="0.0" STUDY_ID="STD-Paquet-1998" TOTAL_1="17" TOTAL_2="23" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.0148608401703" CI_START="0.6501129252417784" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="45" LOG_CI_END="0.47926727079095316" LOG_CI_START="-0.1870111994344772" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2016-02-07 10:12:33 -0500" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="0.391375271542037" STUDY_ID="STD-Seiler-2005" TOTAL_1="64" TOTAL_2="66" VAR="0.15317460317460319" WEIGHT="51.272033074715324"/>
<DICH_DATA CI_END="1.3250517396354882" CI_START="0.26027022135381833" EFFECT_SIZE="0.5872576177285319" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="57" LOG_CI_END="0.12223283661205828" LOG_CI_START="-0.5845755185658711" LOG_EFFECT_SIZE="-0.23117134097690645" MODIFIED="2016-02-07 10:12:33 -0500" MODIFIED_BY="[Empty name]" ORDER="84" O_E="0.0" SE="0.41518272658930117" STUDY_ID="STD-Tran-2004" TOTAL_1="72" TOTAL_2="69" VAR="0.17237669645812642" WEIGHT="48.727966925284676"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="24" EVENTS_2="24" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-02-07 10:12:33 -0500" MODIFIED_BY="[Empty name]" ORDER="85" O_E="0.0" SE="0.0" STUDY_ID="STD-Wenger-1999" TOTAL_1="24" TOTAL_2="24" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-02-05 10:19:49 -0500" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEZCAMAAABxStv9AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-02-05 10:19:49 -0500" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAXIAAAJFCAIAAABP0evWAAAjU0lEQVR42u2dvU4kSRaFU0JCGBgY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</FILE>
</FIGURE>
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-02-05 10:19:42 -0500" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAM0CAYAAACRWKQgAABaWElEQVR42u2dDYRVXRv3H5IkyZBk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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2016-02-07 10:31:58 -0500" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-004.01" SETTINGS="DISTINGUISH_SUBGROUPS:NO;SHOW_EFFECT_ESTIMATE:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_CI_LINES:NO;SHOW_STUDY_NAMES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Survival, outcome: 1.1 Overall.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-005.01" SETTINGS="DISTINGUISH_SUBGROUPS:NO;SHOW_EFFECT_ESTIMATE:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_CI_LINES:NO;SHOW_STUDY_NAMES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 2 Postoperative mortality, outcome: 2.1 Postoperative mortality.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2015-12-03 10:07:48 -0500" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.01" SETTINGS="DISTINGUISH_SUBGROUPS:NO;SHOW_EFFECT_ESTIMATE:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_CI_LINES:NO;SHOW_STUDY_NAMES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 3 Pancreatic fistula, outcome: 3.1 Pancreatic fistula.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<OL>
<LI>exp Pancreatic Neoplasms/</LI>
<LI>(pancrea$ adj5 neoplas$).tw.</LI>
<LI>(pancrea$ adj5 cancer$).tw.</LI>
<LI>(pancrea$ adj5 carcin$).tw.</LI>
<LI>(pancrea$ adj5 tumo$).tw.</LI>
<LI>(pancrea$ adj5 malig$).tw.</LI>
<LI>or/1-6</LI>
<LI>exp pancreatectomy/</LI>
<LI>pancreatectom$.tw.</LI>
<LI>exp pancreaticoduodenectomy/</LI>
<LI>pancreaticoduodenectom$.tw.</LI>
<LI>pancreatoduodenectom$.tw.</LI>
<LI>duodenopancreatectom$.tw.</LI>
<LI>exp pancreaticojejunostomy/</LI>
<LI>pancreaticojejunostom$.tw.</LI>
<LI>pancreatojejunostom$.tw.</LI>
<LI>pancrea$ resect$.tw.</LI>
<LI>whipple.tw.</LI>
<LI>(pylorus adj3 preserv$).tw.</LI>
<LI>or/8-19</LI>
<LI>7 and 20</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<OL>
<LI>exp Pancreatic Neoplasms/</LI>
<LI>(pancrea$ adj5 neoplas$).tw.</LI>
<LI>(pancrea$ adj5 cancer$).tw.</LI>
<LI>(pancrea$ adj5 carcin$).tw.</LI>
<LI>(pancrea$ adj5 tumo$).tw.</LI>
<LI>(pancrea$ adj5 malig$).tw.</LI>
<LI>or/1-6</LI>
<LI>exp pancreatectomy/</LI>
<LI>pancreatectom$.tw.</LI>
<LI>exp pancreaticoduodenectomy/</LI>
<LI>pancreaticoduodenectom$.tw.</LI>
<LI>pancreatoduodenectom$.tw.</LI>
<LI>duodenopancreatectom$.tw.</LI>
<LI>exp pancreaticojejunostomy/</LI>
<LI>pancreaticojejunostom$.tw.</LI>
<LI>pancreatojejunostom$.tw.</LI>
<LI>pancrea$ resect$.tw.</LI>
<LI>whipple.tw.</LI>
<LI>(pylorus adj3 preserv$).tw.</LI>
<LI>or/8-19</LI>
<LI>7 and 20</LI>
<LI>randomized controlled trial.pt.</LI>
<LI>controlled clinical trial.pt.</LI>
<LI>randomized.ab.</LI>
<LI>placebo.ab.</LI>
<LI>drug therapy.fs.</LI>
<LI>randomly.ab.</LI>
<LI>trial.ab.</LI>
<LI>groups.ab.</LI>
<LI>or/22-29</LI>
<LI>exp animals/ not humans.sh.</LI>
<LI>30 not 31</LI>
<LI>21 and 32</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-01-22 11:49:28 -0500" MODIFIED_BY="[Empty name]">
<OL>
<LI>exp Pancreatic Neoplasms/</LI>
<LI>(pancrea$ adj5 neoplas$).tw.</LI>
<LI>(pancrea$ adj5 cancer$).tw.</LI>
<LI>(pancrea$ adj5 carcin$).tw.</LI>
<LI>(pancrea$ adj5 tumo$).tw.</LI>
<LI>(pancrea$ adj5 malig$).tw.</LI>
<LI>or/1-6</LI>
<LI>exp pancreatectomy/</LI>
<LI>pancreatectom$.tw.</LI>
<LI>exp pancreaticoduodenectomy/</LI>
<LI>pancreaticoduodenectom$.tw.</LI>
<LI>pancreatoduodenectom$.tw.</LI>
<LI>duodenopancreatectom$.tw.</LI>
<LI>exp pancreaticojejunostomy/</LI>
<LI>pancreaticojejunostom$.tw.</LI>
<LI>pancreatojejunostom$.tw.</LI>
<LI>pancrea$ resect$.tw.</LI>
<LI>whipple.tw.</LI>
<LI>(pylorus adj3 preserv$).tw.</LI>
<LI>or/8-19</LI>
<LI>7 and 20</LI>
<LI>Clinical trial/</LI>
<LI>Randomized controlled trial/</LI>
<LI>Randomization/</LI>
<LI>Single-Blind Method/</LI>
<LI>Double-Blind Method/</LI>
<LI>Cross-Over Studies/</LI>
<LI>Random Allocation/</LI>
<LI>Placebo/</LI>
<LI>Randomi?ed controlled trial$.tw.</LI>
<LI>Rct.tw.</LI>
<LI>Random allocation.tw.</LI>
<LI>Randomly allocated.tw.</LI>
<LI>Allocated randomly.tw.</LI>
<LI>(allocated adj2 random).tw.</LI>
<LI>Single blind$.tw.</LI>
<LI>Double blind$.tw.</LI>
<LI>((treble or triple) adj blind$).tw.</LI>
<LI>Placebo$.tw.</LI>
<LI>Prospective study/</LI>
<LI>or/22-40</LI>
<LI>Case study/</LI>
<LI>Case report.tw.</LI>
<LI>Abstract report/ or letter/</LI>
<LI>or/42-44</LI>
<LI>41 not 45</LI>
<LI>21 and 46</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2015-08-18 13:26:35 -0400" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2008-05-07 20:21:46 -0400" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-05-07 20:21:57 -0400" MODIFIED_BY="[Empty name]">
<P>(1) exp Pancreatic Neoplasms/<BR/>(2) (pancrea$ adj5 neoplas$).tw.<BR/>(3) (pancrea$ adj5 cancer$).tw.<BR/>(4) (pancrea$ adj5 carcin$).tw.<BR/>(5) (pancrea$ adj5 tumo$).tw.<BR/>(6) (pancrea$ adj5 malig$).tw.<BR/>(7) or/2-6<BR/>(8) exp pancreatectomy/<BR/>(9) pancreatectom$.tw.<BR/>(10) exp pancreaticoduodenectomy/<BR/>(11) pancreaticoduodenectom$.tw.<BR/>(12) pancreatoduodenectom$.tw.<BR/>(13) duodenopancreatectom$.tw.<BR/>(14) exp pancreaticojejunostomy/<BR/>(15) pancreaticojejunostom$.tw.<BR/>(16) pancreatojejunostom$.tw.<BR/>(17) pancrea$ resect$.tw.<BR/>(18) whipple.tw.<BR/>(19) (pylorus adj3 preserv$).tw.<BR/>(20) or/8-19<BR/>(21) 7 and 20</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2008-05-07 20:25:51 -0400" MODIFIED_BY="[Empty name]">Data extraction details</TITLE>
<APPENDIX_BODY MODIFIED="2016-02-07 16:21:45 -0500" MODIFIED_BY="[Empty name]">
<P>We extracted the following data.</P>
<UL>
<LI>Title, authors, contact address.</LI>
<LI>Source.</LI>
<LI>Published/unpublished.</LI>
<LI>Year of publication.</LI>
<LI>Trial sponsors.</LI>
<LI>Method of randomisation.</LI>
<LI>Blinding of outcome assessor, participant, and treating physician.</LI>
<LI>Criteria for patient inclusion and exclusion.</LI>
<LI>Sample size and sample size calculation.</LI>
<LI>Baseline characteristics and similarities of groups at baseline.</LI>
<LI>Withdrawals and losses to follow-up.</LI>
<LI>Participant characteristics including mean/median age, age range, sex ratio.</LI>
<LI>Specific pancreatic diagnosis leading to surgical intervention.</LI>
<LI>Number of participants assigned to each treatment group.</LI>
<LI>Details of intervention regimens.</LI>
<LI>Survival related to each intervention (hazard ratios and their 95% confidence intervals, log-rank Chi² values, log-rank P values).</LI>
<LI>Postoperative mortality related to each intervention.</LI>
<LI>Number of lymph nodes removed in each group.</LI>
<LI>Status of resection margins.</LI>
<LI>Intraoperative blood loss related to each intervention.</LI>
<LI>Operation time related to each intervention.</LI>
<LI>Duration of hospital stay related to each intervention.</LI>
<LI>Definition of postoperative complications.</LI>
<LI>Number and frequency of postoperative complications related to each intervention.</LI>
<LI>Definitions of adverse reactions and outcomes.</LI>
<LI>Adverse reactions and outcomes.</LI>
<LI>Quality of life.</LI>
</UL>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_3" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="3">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 trials (9 publications) included in review&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;25 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2956 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2335 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;621 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;2931 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;16 full-text articles excluded due to:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;No comparison of PPW versus CW (n = 10)&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Non-randomised study design (n = 3)&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Study not randomised for the comparison of PPW versus CW (n = 1)&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Narrative review of one included RCT (n = 1)&lt;/li&gt;&lt;/ul&gt;&lt;ul&gt;&lt;li&gt;Additional publication on the same trial (n = 1)&lt;/li&gt;&lt;/ul&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>